| 1 | confounding | 2,243 |
| 2 | covariate | 1,011 |
| 3 | modifiable | 879 |
| 4 | predisposing | 810 |
| 5 | explanatory | 618 |
| 6 | drug-drug | 510 |
| 7 | π-π | 268 |
| 8 | stacking | 238 |
| 9 | precipitating | 199 |
| 10 | protein-protein | 179 |
| 11 | unmeasured | 172 |
| 12 | group-by-time | 151 |
| 13 | contributory | 149 |
| 14 | aggravating | 113 |
| 15 | confounder | 96 |
| 16 | herb-drug | 96 |
| 17 | c-h⋯π | 93 |
| 18 | hydrogen-bonding | 85 |
| 19 | gene-environment | 72 |
| 20 | case-mix | 56 |
| 21 | group×time | 45 |
| 22 | gene-gene | 44 |
| 23 | protein-ligand | 39 |
| 24 | host-pathogen | 38 |
| 25 | drug-disease | 34 |
| 26 | drug-herb | 33 |
| 27 | time-by-group | 31 |
| 28 | treatment-by-time | 29 |
| 29 | h-bonding | 28 |
| 30 | epistatic | 27 |
| 31 | gene-diet | 26 |
| 32 | nonmodifiable | 25 |
| 33 | treatment-time | 24 |
| 34 | dipole-dipole | 22 |
| 35 | hyper-conjugative | 22 |
| 36 | non-modifiable | 20 |
| 37 | drug-food | 19 |
| 38 | time-by-treatment | 18 |
| 39 | π-stacking | 18 |
| 40 | virus-host | 17 |
| 41 | c-h···π | 16 |
| 42 | host-microbe | 15 |
| 43 | hyperconjugative | 15 |
| 44 | receptor-ligand | 15 |
| 45 | covariable | 14 |
| 46 | herb-herb | 14 |
| 47 | treatment-by-subgroup | 14 |
| 48 | roter | 13 |
| 49 | unmodifiable | 13 |
| 50 | π···π | 13 |
| 51 | food-drug | 12 |
| 52 | group-time | 12 |
| 53 | actin-myosin | 11 |
| 54 | aurophilic | 11 |
| 55 | drug-target | 11 |
| 56 | prerandomisation | 11 |
| 57 | time-group | 11 |
| 58 | condition-by-time | 10 |
| 59 | lipoprotein-related | 10 |
| 60 | plant-pathogen | 10 |
| 61 | treatment-subgroup | 10 |
| 62 | dipole-quadrupole | 9 |
| 63 | dna-protein | 9 |
| 64 | effect-modifying | 9 |
| 65 | gene-by-environment | 9 |
| 66 | risk/protective | 9 |
| 67 | time×treatment | 9 |
| 68 | treatment-covariate | 9 |
| 69 | treatment×time | 9 |
| 70 | amblyogenic | 8 |
| 71 | assessment-based | 8 |
| 72 | rna-rna | 8 |
| 73 | superexchange | 8 |
| 74 | time×group | 8 |
| 75 | ventricular-ventricular | 8 |
| 76 | drug-statin | 7 |
| 77 | drug-to-drug | 7 |
| 78 | gene-drug | 7 |
| 79 | herbal-drug | 7 |
| 80 | interracial | 7 |
| 81 | mdm2/p53 | 7 |
| 82 | treatment-by-covariate | 7 |
| 83 | anion-π | 6 |
| 84 | baseline-by-treatment | 6 |
| 85 | cross-level | 6 |
| 86 | fluid-structure | 6 |
| 87 | gene-treatment | 6 |
| 88 | human-robot | 6 |
| 89 | ligand-target | 6 |
| 90 | nonbonding | 6 |
| 91 | panic-relevant | 6 |
| 92 | time*group | 6 |
| 93 | treatment-by-age | 6 |
| 94 | actor-partner | 5 |
| 95 | aetiopathogenetic | 5 |
| 96 | age-by-treatment | 5 |
| 97 | alterable | 5 |
| 98 | aptitude-treatment | 5 |
| 99 | caries-related | 5 |
| 100 | cation-cation | 5 |
| 101 | cation-π | 5 |
| 102 | co-variate | 5 |
| 103 | diet-gene | 5 |
| 104 | drug-excipient | 5 |
| 105 | drug-receptor | 5 |
| 106 | drug-supplement | 5 |
| 107 | edge-to-face | 5 |
| 108 | epithelial-stromal | 5 |
| 109 | host-microbial | 5 |
| 110 | laser-tissue | 5 |
| 111 | medical/obstetric | 5 |
| 112 | n-h⋯f | 5 |
| 113 | polymer-nanorod | 5 |
| 114 | protein/protein | 5 |
| 115 | time-treatment | 5 |
| 116 | treatment-biomarker | 5 |
| 117 | π-cation | 5 |
| 118 | π–π | 5 |
| 119 | air-sea | 4 |
| 120 | blood-tissue | 4 |
| 121 | catalase-amyloid | 4 |
| 122 | chemical-protein | 4 |
| 123 | chias | 4 |
| 124 | covariate-treatment | 4 |
| 125 | diet-drug | 4 |
| 126 | drug-nutrient | 4 |
| 127 | enzyme-ligand | 4 |
| 128 | framingham-based | 4 |
| 129 | gas-surface | 4 |
| 130 | gene-nutrient | 4 |
| 131 | gene/environment | 4 |
| 132 | genes/environment | 4 |
| 133 | genotype-by-treatment | 4 |
| 134 | genotype-treatment | 4 |
| 135 | host-virus | 4 |
| 136 | kissing-loop | 4 |
| 137 | lens-solution | 4 |
| 138 | ligand-ligand | 4 |
| 139 | molecule-protein | 4 |
| 140 | nh···o | 4 |
| 141 | nonradiation | 4 |
| 142 | nutrient-drug | 4 |
| 143 | pi-pi | 4 |
| 144 | sex-by-treatment | 4 |
| 145 | snp-diet | 4 |
| 146 | time-by-condition | 4 |
| 147 | treatment-by-centre | 4 |
| 148 | treatment-by-gender | 4 |
| 149 | treatment-by-histology | 4 |
| 150 | tumor-stroma | 4 |
| 151 | unit-treatment | 4 |
| 152 | vertebra-specific | 4 |
| 153 | ag⋯f | 3 |
| 154 | antiferro-magnetic | 3 |
| 155 | attribute-treatment | 3 |
| 156 | cross-partner | 3 |
| 157 | cuprophilic | 3 |
| 158 | drug-alcohol | 3 |
| 159 | drug-by-time | 3 |
| 160 | drug-laboratory | 3 |
| 161 | encephalographic | 3 |
| 162 | erα/14-3-3 | 3 |
| 163 | gene-by-treatment | 3 |
| 164 | group×time×sex | 3 |
| 165 | host-bacteria | 3 |
| 166 | host-parasitoid | 3 |
| 167 | hsp90-gch1 | 3 |
| 168 | hsp90-inrf2 | 3 |
| 169 | hydrogen-bond-like | 3 |
| 170 | integrin-kindlin-3 | 3 |
| 171 | leukocyte-endothelium | 3 |
| 172 | lung-heart | 3 |
| 173 | mdm2-p53 | 3 |
| 174 | microbe-host | 3 |
| 175 | mirna-mrna | 3 |
| 176 | nature-nurture | 3 |
| 177 | non-radiation | 3 |
| 178 | nonreciprocal | 3 |
| 179 | nutrient-gene | 3 |
| 180 | nutrient-nutrient | 3 |
| 181 | paip1-eif3 | 3 |
| 182 | parasocial | 3 |
| 183 | pi-cation | 3 |
| 184 | plant-microbe | 3 |
| 185 | pollen-pistil | 3 |
| 186 | protein-glycan | 3 |
| 187 | protein-rna | 3 |
| 188 | rankl-rank | 3 |
| 189 | severity-of-illness | 3 |
| 190 | snp-education | 3 |
| 191 | staff-caregiver | 3 |
| 192 | study-by-treatment | 3 |
| 193 | subgroup-by-treatment | 3 |
| 194 | subject-by-formulation | 3 |
| 195 | subject-treatment | 3 |
| 196 | supplement-drug | 3 |
| 197 | task-rule | 3 |
| 198 | through-space | 3 |
| 199 | treatment-by-biomarker | 3 |
| 200 | treatment-by-center | 3 |
| 201 | treatment-by-genotype | 3 |
| 202 | treatment-by-sex | 3 |
| 203 | vector-pathogen | 3 |
| 204 | π-π-stacking | 3 |
| 205 | /p23 | 2 |
| 206 | 14-3-3/cby | 2 |
| 207 | aba-hsp70 | 2 |
| 208 | acd-cam | 2 |
| 209 | adipor1/cav-3 | 2 |
| 210 | aetiopathogenic | 2 |
| 211 | age-by-sex | 2 |
| 212 | age-treatment | 2 |
| 213 | al-au-al/b-au-al | 2 |
| 214 | amyloid-tau | 2 |
| 215 | anion-anion | 2 |
| 216 | ap-3-clathrin | 2 |
| 217 | arene-perfluoroarene | 2 |
| 218 | arginine-arene | 2 |
| 219 | arsenic/cadmium | 2 |
| 220 | as/14-3-3η | 2 |
| 221 | atg14l-vps34/vps15 | 2 |
| 222 | au-au | 2 |
| 223 | bacteria-host | 2 |
| 224 | c-h⋯ocarbon-yl | 2 |
| 225 | cell-ecm | 2 |
| 226 | ch···o | 2 |
| 227 | compliance-treatment | 2 |
| 228 | condition×time | 2 |
| 229 | cpc7 | 2 |
| 230 | dbc1-sirt1 | 2 |
| 231 | diagnosis×time | 2 |
| 232 | dromotropic | 2 |
| 233 | drug-cell | 2 |
| 234 | drug-membrane | 2 |
| 235 | electron-vibration | 2 |
| 236 | emotion-cognition | 2 |
| 237 | environment-speed | 2 |
| 238 | excluded-volume | 2 |
| 239 | fe-o-mn | 2 |
| 240 | fronte | 2 |
| 241 | gal-3-inhibitor | 2 |
| 242 | gas-wall | 2 |
| 243 | gas/surface | 2 |
| 244 | gender-treatment | 2 |
| 245 | gene-by-dose | 2 |
| 246 | gene-by-smoking | 2 |
| 247 | gene-lifestyle | 2 |
| 248 | gene×environment | 2 |
| 249 | genotype-by-diagnosis | 2 |
| 250 | genotype-by-intervention | 2 |
| 251 | group*session | 2 |
| 252 | group-by-emotion | 2 |
| 253 | group-x-time | 2 |
| 254 | group×time×grade | 2 |
| 255 | g×t | 2 |
| 256 | ha-glycan | 2 |
| 257 | halogen-halogen | 2 |
| 258 | hcv-host | 2 |
| 259 | heme-ligand | 2 |
| 260 | high-friction | 2 |
| 261 | histology-by-treatment | 2 |
| 262 | host-fungus | 2 |
| 263 | host-organism | 2 |
| 264 | human-microbe | 2 |
| 265 | influenceable | 2 |
| 266 | inter-sexual | 2 |
| 267 | interpeptide | 2 |
| 268 | intra-sensory | 2 |
| 269 | iop-independent | 2 |
| 270 | light-tissue | 2 |
| 271 | loading-related | 2 |
| 272 | lung-kidney | 2 |
| 273 | metabolic-based | 2 |
| 274 | metal-coordinating | 2 |
| 275 | mirna/mrna | 2 |
| 276 | molecule-substrate | 2 |
| 277 | mother-children | 2 |
| 278 | mu-9-csap | 2 |
| 279 | nectin-afadin | 2 |
| 280 | neutrophil/endothelial | 2 |
| 281 | non-bonding | 2 |
| 282 | nutrient-disease | 2 |
| 283 | olfactory-visual | 2 |
| 284 | organization-level | 2 |
| 285 | overtaking | 2 |
| 286 | oxygen-temperature | 2 |
| 287 | ozone-heat | 2 |
| 288 | p311-eif3b | 2 |
| 289 | p53/mdm2 | 2 |
| 290 | parent/infant | 2 |
| 291 | pathogen-host | 2 |
| 292 | peer-client | 2 |
| 293 | peptide-mediated | 2 |
| 294 | plasma-tissue | 2 |
| 295 | plasmon-exciton | 2 |
| 296 | post-assault | 2 |
| 297 | ppi-clopidogrel | 2 |
| 298 | preinstruction | 2 |
| 299 | previously-unknown | 2 |
| 300 | program-by-client | 2 |
| 301 | protein-oligonucleotide | 2 |
| 302 | protein-polyphenol | 2 |
| 303 | protein-solvent | 2 |
| 304 | psp94-crisp-3 | 2 |
| 305 | race-treatment | 2 |
| 306 | randomization-by-time | 2 |
| 307 | rest-task | 2 |
| 308 | rs738409-sex | 2 |
| 309 | rydberg-valence | 2 |
| 310 | second-neighbor | 2 |
| 311 | session*time | 2 |
| 312 | sex-by-time | 2 |
| 313 | sex-diabetes | 2 |
| 314 | sexual-partner-related | 2 |
| 315 | sleep-disturbing | 2 |
| 316 | snp-snp | 2 |
| 317 | sp-a/crp | 2 |
| 318 | sperm/mucus | 2 |
| 319 | stent-vessel | 2 |
| 320 | stress-hemoconcentration | 2 |
| 321 | substrate-enzyme | 2 |
| 322 | system-reservoir | 2 |
| 323 | s···o | 2 |
| 324 | tau-tau | 2 |
| 325 | tg2-fn | 2 |
| 326 | through-bond | 2 |
| 327 | time-by-regimen | 2 |
| 328 | tms-2 | 2 |
| 329 | tooth-composite | 2 |
| 330 | trainer-trainee | 2 |
| 331 | trait×situation | 2 |
| 332 | translation-independent | 2 |
| 333 | treatment-by-age-group | 2 |
| 334 | treatment-by-baseline | 2 |
| 335 | treatment-by-bmi | 2 |
| 336 | treatment-by-country | 2 |
| 337 | treatment-by-factor | 2 |
| 338 | treatment-by-gfr | 2 |
| 339 | treatment-by-race | 2 |
| 340 | treatment-by-region | 2 |
| 341 | treatment-by-strata | 2 |
| 342 | treatment-by-study | 2 |
| 343 | treatment-by-subset | 2 |
| 344 | treatment-by-volume | 2 |
| 345 | treatment-gender | 2 |
| 346 | treatment-visit | 2 |
| 347 | trial-by-time | 2 |
| 348 | troponin-c | 2 |
| 349 | v-rr | 2 |
| 350 | vector-parasite | 2 |
| 351 | virtual-human | 2 |
| 352 | virus/host | 2 |
| 353 | zno×phytase | 2 |
| 354 | -by-time | 1 |
| 355 | -enzyme | 1 |
| 356 | -glycan | 1 |
| 357 | -lacy | 1 |
| 358 | -ph···co | 1 |
| 359 | -ph···cr | 1 |
| 360 | /hsp90 | 1 |
| 361 | /kaiso | 1 |
| 362 | /membrane | 1 |
| 363 | /rhoa | 1 |
| 364 | 1,3-equatorial | 1 |
| 365 | 1,3-syn-axial | 1 |
| 366 | 14-3-3/client | 1 |
| 367 | 14-3-3ɛ-vdac1 | 1 |
| 368 | 14-3-3ζ-client | 1 |
| 369 | 14-3-3ζ-ezrin | 1 |
| 370 | 14-3-3ζ-phosphoprotein | 1 |
| 371 | 14-3-3ζ/gabab1 | 1 |
| 372 | 3'-bte-5'-utr | 1 |
| 373 | 32-core | 1 |
| 374 | 5-hmf-hsa/bsa | 1 |
| 375 | a-minor | 1 |
| 376 | actin-arp2/3 | 1 |
| 377 | activity-treatment | 1 |
| 378 | additivity/indifference | 1 |
| 379 | adsorbate-adsorbate | 1 |
| 380 | aea-hsp | 1 |
| 381 | affinity-like | 1 |
| 382 | ag-ligand | 1 |
| 383 | age-by-gender | 1 |
| 384 | age-by-gender-by-framing | 1 |
| 385 | age-by-gender-by-treatment | 1 |
| 386 | age-drug | 1 |
| 387 | age-rasagiline | 1 |
| 388 | age-smoking | 1 |
| 389 | agency-structure | 1 |
| 390 | agmatine-cannabinoid | 1 |
| 391 | al-c | 1 |
| 392 | aldolase-actin | 1 |
| 393 | amine-water | 1 |
| 394 | ammonium-quartz | 1 |
| 395 | angio-associated | 1 |
| 396 | animal-born | 1 |
| 397 | animal-fluid | 1 |
| 398 | anti-malarial-anti-retroviral | 1 |
| 399 | anti-tnp/tnp | 1 |
| 400 | antibiotic-drug | 1 |
| 401 | antibody-pathogen | 1 |
| 402 | antibody/toxin | 1 |
| 403 | antiperiplanar | 1 |
| 404 | apelin/receptor | 1 |
| 405 | api/polymer | 1 |
| 406 | apolipoprotein-cell | 1 |
| 407 | argentophilic | 1 |
| 408 | arms-by-visits | 1 |
| 409 | aromatic-aromatic | 1 |
| 410 | aromatic-ring | 1 |
| 411 | arterial-heart | 1 |
| 412 | artn-gfrα3 | 1 |
| 413 | au-mn | 1 |
| 414 | auditory-to-motor | 1 |
| 415 | au···au | 1 |
| 416 | ay23-trypsin | 1 |
| 417 | bacteria-immune | 1 |
| 418 | bacteria-uc | 1 |
| 419 | bacterial/hab | 1 |
| 420 | base-phosphate | 1 |
| 421 | bcl2-becn1 | 1 |
| 422 | between-ed-subgroup | 1 |
| 423 | between-language | 1 |
| 424 | birds/human | 1 |
| 425 | bjp-thp | 1 |
| 426 | blood-material | 1 |
| 427 | blood-membrane | 1 |
| 428 | blood-surface | 1 |
| 429 | blood-valve | 1 |
| 430 | bmd-related | 1 |
| 431 | bmi*diet | 1 |
| 432 | botanical-drug | 1 |
| 433 | both-through | 1 |
| 434 | brain-catecholamine | 1 |
| 435 | br⋯n | 1 |
| 436 | br⋯ometh-oxy | 1 |
| 437 | br⋯onitro | 1 |
| 438 | bubble-bubble | 1 |
| 439 | bullxtreatment | 1 |
| 440 | bbmn | 1 |
| 441 | c-h···ti | 1 |
| 442 | c6-b | 1 |
| 443 | c60-water | 1 |
| 444 | c=o⋯π | 1 |
| 445 | caf-epithelial | 1 |
| 446 | caffeine-extraversion | 1 |
| 447 | caffeine-haemoglobin | 1 |
| 448 | calcium-iron | 1 |
| 449 | capase-3/calbindin-d28k | 1 |
| 450 | carbohydrate-lectin | 1 |
| 451 | carbon-substituted | 1 |
| 452 | carbonyl-carbonyl | 1 |
| 453 | cardiac/noncardiac | 1 |
| 454 | carom-h⋯o | 1 |
| 455 | casa-derived | 1 |
| 456 | caseworker-recipient | 1 |
| 457 | catalase-aβ | 1 |
| 458 | category-comprising | 1 |
| 459 | cation-pi | 1 |
| 460 | cb1/trpv1 | 1 |
| 461 | cb2/hsp90 | 1 |
| 462 | ccna2-drug | 1 |
| 463 | ccr4-ligand | 1 |
| 464 | cc⋯ho | 1 |
| 465 | cd28/b7 | 1 |
| 466 | cd40/cd154 | 1 |
| 467 | cell-apolipoprotein | 1 |
| 468 | cell-cell-mediated | 1 |
| 469 | cell/phbhhx-l | 1 |
| 470 | cell/surface | 1 |
| 471 | cell–matrix | 1 |
| 472 | center-surround | 1 |
| 473 | centre-treatment | 1 |
| 474 | chemo-biological | 1 |
| 475 | child-family | 1 |
| 476 | child-robot | 1 |
| 477 | cholinoreceptor | 1 |
| 478 | chp-drug | 1 |
| 479 | ch₃cn-ch₃cn | 1 |
| 480 | ch⋯π | 1 |
| 481 | cl-s | 1 |
| 482 | client-professional | 1 |
| 483 | clinician‒patient | 1 |
| 484 | clinicoroentgenological | 1 |
| 485 | clopidogrel-drug | 1 |
| 486 | clopidogrel-ppi | 1 |
| 487 | cloud-aerosol | 1 |
| 488 | cluster-defining | 1 |
| 489 | cl⋅⋅⋅c | 1 |
| 490 | co-surface | 1 |
| 491 | co2-zeolite | 1 |
| 492 | coach-patient | 1 |
| 493 | coaggregative | 1 |
| 494 | colah-collagen | 1 |
| 495 | commensal-immune | 1 |
| 496 | complexity-by-intervention | 1 |
| 497 | condition-by-education | 1 |
| 498 | condition-time | 1 |
| 499 | condition/time | 1 |
| 500 | condition×sequence | 1 |
| 501 | confounder-exposure | 1 |
| 502 | copper-prion | 1 |
| 503 | copper-selenium | 1 |
| 504 | coral-cca | 1 |
| 505 | coral-turf | 1 |
| 506 | core/electron-electron | 1 |
| 507 | coronavirus-receptor | 1 |
| 508 | corticosteroid-herb | 1 |
| 509 | corticosteroid-licorice | 1 |
| 510 | cost-driving | 1 |
| 511 | coulombian | 1 |
| 512 | coupling/decoupling | 1 |
| 513 | covariate-by-treatment | 1 |
| 514 | cp-hsp70 | 1 |
| 515 | cpox4-hg | 1 |
| 516 | cpr6-hsp90 | 1 |
| 517 | cpsf-aauaaa | 1 |
| 518 | cpsf30-rna | 1 |
| 519 | cross-exon | 1 |
| 520 | crown-to-crown | 1 |
| 521 | crp-drug | 1 |
| 522 | csa-isoprenaline | 1 |
| 523 | csa-β-adrenoceptor | 1 |
| 524 | cta1-chaperone | 1 |
| 525 | ctx-upa/pai-1 | 1 |
| 526 | cx43-hsc70 | 1 |
| 527 | cyanophage-host | 1 |
| 528 | database/target | 1 |
| 529 | day*energy | 1 |
| 530 | day×gel | 1 |
| 531 | ddx3-irf3 | 1 |
| 532 | depression-by-ptsd | 1 |
| 533 | device-device | 1 |
| 534 | device-drug | 1 |
| 535 | dexamethasone/aprepitant | 1 |
| 536 | diabetic-disease | 1 |
| 537 | dicer1-p-smad2/3 | 1 |
| 538 | diet-genotype | 1 |
| 539 | diet-microbiota | 1 |
| 540 | diet-time | 1 |
| 541 | digoxin-gender | 1 |
| 542 | dimer-substrate | 1 |
| 543 | diphylla-insect | 1 |
| 544 | dipole-quadruple | 1 |
| 545 | disease-target | 1 |
| 546 | disulfiram-chloral | 1 |
| 547 | dll4-notch1 | 1 |
| 548 | dna-drug | 1 |
| 549 | dna-ligand | 1 |
| 550 | dnaa-oric | 1 |
| 551 | doctor-parent | 1 |
| 552 | dopamine/dmpg | 1 |
| 553 | dose-by-time | 1 |
| 554 | dose-form | 1 |
| 555 | dronedarone-digoxin | 1 |
| 556 | drug-bilirubin | 1 |
| 557 | drug-by-age | 1 |
| 558 | drug-by-predictor | 1 |
| 559 | drug-cam | 1 |
| 560 | drug-channel | 1 |
| 561 | drug-cranberry | 1 |
| 562 | drug-enzyme | 1 |
| 563 | drug-excipients | 1 |
| 564 | drug-flavonoid | 1 |
| 565 | drug-gene | 1 |
| 566 | drug-herb/herb-herb | 1 |
| 567 | drug-herbs | 1 |
| 568 | drug-metabolite | 1 |
| 569 | drug-micronutrient | 1 |
| 570 | drug-milk | 1 |
| 571 | drug-organism | 1 |
| 572 | drug-personality | 1 |
| 573 | drug-pregnancy | 1 |
| 574 | drug-steroid | 1 |
| 575 | drug-vitamin-herbal | 1 |
| 576 | drug/disease | 1 |
| 577 | drug/t1301 | 1 |
| 578 | drug×time | 1 |
| 579 | drug–drug | 1 |
| 580 | drug–food | 1 |
| 581 | ds-drug | 1 |
| 582 | dye-light | 1 |
| 583 | dzyaloshinskii-moriya | 1 |
| 584 | ebs3-ibs3 | 1 |
| 585 | effect-covariate | 1 |
| 586 | efficiency-property-pharmacology-target-protein | 1 |
| 587 | egcg-bsa | 1 |
| 588 | eliminable | 1 |
| 589 | emerged-medicinal | 1 |
| 590 | empathy×content | 1 |
| 591 | end-orientation | 1 |
| 592 | endocardial-endothelial/cardiomyocyte | 1 |
| 593 | endocrine-immune-paracrine | 1 |
| 594 | endothelin-ra | 1 |
| 595 | energy-by-protein | 1 |
| 596 | environment-behavior | 1 |
| 597 | enzyme-drug | 1 |
| 598 | epinephrine/hypertensive | 1 |
| 599 | epistatic-environmental-biological | 1 |
| 600 | epithelial-bacterial | 1 |
| 601 | epithelium-gamete | 1 |
| 602 | er-level | 1 |
| 603 | er-striatin | 1 |
| 604 | erα/chromatin | 1 |
| 605 | estrogen-serotonin | 1 |
| 606 | estrogen-stress | 1 |
| 607 | ethnicity-by-education | 1 |
| 608 | ethnicity-by-ep | 1 |
| 609 | etra/etrb | 1 |
| 610 | exercise-nutrient | 1 |
| 611 | expectations-realization | 1 |
| 612 | fab-fab | 1 |
| 613 | fat-carbohydrate | 1 |
| 614 | feedback-this | 1 |
| 615 | filler-rubber | 1 |
| 616 | flavonoid-abc-transporter | 1 |
| 617 | flory | 1 |
| 618 | food-by-dose | 1 |
| 619 | food-web | 1 |
| 620 | four-body | 1 |
| 621 | fpr-specific | 1 |
| 622 | fröhlich | 1 |
| 623 | fullerene-water | 1 |
| 624 | fungal/crop/environment | 1 |
| 625 | fungus-host | 1 |
| 626 | fungus-insect | 1 |
| 627 | gal-3/bax | 1 |
| 628 | gal-3/gal-3 | 1 |
| 629 | galectin-3/polylacnac | 1 |
| 630 | gastrointestinal-respiratory | 1 |
| 631 | gch1-chip | 1 |
| 632 | gemfibrozil-repaglinide | 1 |
| 633 | gender-by-diagnosis | 1 |
| 634 | gender-by-lisinopril/amlodipine | 1 |
| 635 | gender-by-race | 1 |
| 636 | gender-cue | 1 |
| 637 | gender-drug | 1 |
| 638 | gender-gene | 1 |
| 639 | gender-to-diet | 1 |
| 640 | gender/lithium | 1 |
| 641 | gender×condition | 1 |
| 642 | gender×mets | 1 |
| 643 | gene*diet | 1 |
| 644 | gene-b-vitamin | 1 |
| 645 | gene-by-flavonoid | 1 |
| 646 | gene-by-gender | 1 |
| 647 | gene-by-sex | 1 |
| 648 | gene-concentration | 1 |
| 649 | gene-nutritional | 1 |
| 650 | gene-smoking | 1 |
| 651 | genetic-environment | 1 |
| 652 | genetic/environment | 1 |
| 653 | gene×gene | 1 |
| 654 | genome-environment | 1 |
| 655 | genotype-by-environment | 1 |
| 656 | genotype-by-sex | 1 |
| 657 | genotype-by-time | 1 |
| 658 | genotype-genotype | 1 |
| 659 | genotype-intervention | 1 |
| 660 | genotype-time | 1 |
| 661 | genotype/drug | 1 |
| 662 | genotype/treatment | 1 |
| 663 | gesture-based | 1 |
| 664 | gfj-drug | 1 |
| 665 | gfj-fexofenadine | 1 |
| 666 | gfj-loperamide | 1 |
| 667 | gh14-3-3-ghbzr1 | 1 |
| 668 | glap-rage | 1 |
| 669 | glycan-glycan | 1 |
| 670 | glycan-lectin | 1 |
| 671 | gonadotrophin-dose | 1 |
| 672 | gp120-cd4 | 1 |
| 673 | gpr30-ramp3 | 1 |
| 674 | gpr43-scfa | 1 |
| 675 | group*weeks | 1 |
| 676 | group-by-age | 1 |
| 677 | group-by-sex | 1 |
| 678 | group-by-soc | 1 |
| 679 | group-by-speed | 1 |
| 680 | group-by-stage | 1 |
| 681 | group-by-task | 1 |
| 682 | group-by-time-by-arm | 1 |
| 683 | group-by-visit | 1 |
| 684 | group-region | 1 |
| 685 | groups*period | 1 |
| 686 | group×load×time | 1 |
| 687 | group×time×education | 1 |
| 688 | growth/inhibitory | 1 |
| 689 | gsk-3-shared | 1 |
| 690 | guanine-zno | 1 |
| 691 | guideline-level | 1 |
| 692 | g×e | 1 |
| 693 | h3.3k36me3/bs69 | 1 |
| 694 | haeme-protein | 1 |
| 695 | haplotype-drug | 1 |
| 696 | hb101-uc | 1 |
| 697 | hba1c/ethnicity | 1 |
| 698 | hbd-3-cxcr4 | 1 |
| 699 | head-rod | 1 |
| 700 | heat-exacerbating | 1 |
| 701 | her2/her3 | 1 |
| 702 | herbdrug | 1 |
| 703 | herbs-drugs | 1 |
| 704 | hg-drug | 1 |
| 705 | higher-body | 1 |
| 706 | histone-protein | 1 |
| 707 | hn-f | 1 |
| 708 | hn-receptor | 1 |
| 709 | hnrnpk-dna | 1 |
| 710 | homocysteine-gene | 1 |
| 711 | hormone-brain-behavior | 1 |
| 712 | host-agent | 1 |
| 713 | host-donor | 1 |
| 714 | host-host | 1 |
| 715 | host-microflora | 1 |
| 716 | host-pathogens | 1 |
| 717 | host/guest | 1 |
| 718 | host/pathogen | 1 |
| 719 | host∶parasite | 1 |
| 720 | hsf1/dhse | 1 |
| 721 | hsp-receptor | 1 |
| 722 | hsp20-pde4d | 1 |
| 723 | hsp27/tlr3 | 1 |
| 724 | hsp70-hla-dr | 1 |
| 725 | hsp90/cdc37 | 1 |
| 726 | hsp90/gch1 | 1 |
| 727 | hsp90β/p23 | 1 |
| 728 | human-forest | 1 |
| 729 | human-raccoon | 1 |
| 730 | human/environment | 1 |
| 731 | human/environmental/cultural | 1 |
| 732 | hyperconjucative | 1 |
| 733 | h···cl | 1 |
| 734 | ibuprofen/aspirin | 1 |
| 735 | icd/drug | 1 |
| 736 | ih901-training | 1 |
| 737 | in-tnpo3 | 1 |
| 738 | inducer-receptor | 1 |
| 739 | industry-physician | 1 |
| 740 | infant/parent | 1 |
| 741 | infusion-rates | 1 |
| 742 | initiator-oric | 1 |
| 743 | initiator-origin | 1 |
| 744 | insect-pathogen | 1 |
| 745 | intake-producer | 1 |
| 746 | integrin-toxin | 1 |
| 747 | inter-chromosomal | 1 |
| 748 | inter-collegial | 1 |
| 749 | inter-herbal | 1 |
| 750 | inter-moiety | 1 |
| 751 | inter-trimer | 1 |
| 752 | interologous | 1 |
| 753 | intervention*age | 1 |
| 754 | intervention-by-age | 1 |
| 755 | intetumumab-dacarbazine | 1 |
| 756 | intra-herb | 1 |
| 757 | intra-layer | 1 |
| 758 | intra-solvent | 1 |
| 759 | intramyotubularin | 1 |
| 760 | inv-integrin | 1 |
| 761 | ion-matter | 1 |
| 762 | ipaf-macrophage | 1 |
| 763 | irf3/ikkβ | 1 |
| 764 | item-unspecific | 1 |
| 765 | ki-drug | 1 |
| 766 | kif23-14-3-3 | 1 |
| 767 | kindlin-3-β2-integrin | 1 |
| 768 | kubas | 1 |
| 769 | laser-matter | 1 |
| 770 | laser-metal | 1 |
| 771 | lectin-glycan | 1 |
| 772 | ledgf/p75-in | 1 |
| 773 | lef-3-lef-3 | 1 |
| 774 | leukocyte-epithelial | 1 |
| 775 | leukocyte-platelet-endothelial | 1 |
| 776 | leukoycte-endothelial | 1 |
| 777 | lfa-3/cd2 | 1 |
| 778 | ligand-core | 1 |
| 779 | ligand-macromolecule | 1 |
| 780 | light-water | 1 |
| 781 | lipid-lipid | 1 |
| 782 | liquorice-herb/drug | 1 |
| 783 | ll-37/dna | 1 |
| 784 | lmir5-c24:1 | 1 |
| 785 | lnk-jak2 | 1 |
| 786 | lo18-membrane | 1 |
| 787 | lumo-lumo | 1 |
| 788 | lvef-by-treatment | 1 |
| 789 | machine-human | 1 |
| 790 | magnetostatic | 1 |
| 791 | many-to-one-by-condition | 1 |
| 792 | marker-treatment | 1 |
| 793 | material-implant | 1 |
| 794 | maternal/offspring | 1 |
| 795 | mb-protein | 1 |
| 796 | md-2/zaa | 1 |
| 797 | mdm2-nucleophosmin | 1 |
| 798 | medication-by-time | 1 |
| 799 | medications/drug | 1 |
| 800 | medication×stress×trial | 1 |
| 801 | meevd-tpr | 1 |
| 802 | met-hsp83 | 1 |
| 803 | metal-methane | 1 |
| 804 | metal-to-cluster | 1 |
| 805 | metal···π | 1 |
| 806 | metformin×exercise | 1 |
| 807 | methyl-ene-bromo-benzene | 1 |
| 808 | mg-cd | 1 |
| 809 | mg-p | 1 |
| 810 | microalgae/bacteria | 1 |
| 811 | microbial-host | 1 |
| 812 | microbial-microbial | 1 |
| 813 | microbiota-hormone | 1 |
| 814 | microglial-neuronal | 1 |
| 815 | mind-brain-body | 1 |
| 816 | mirna-target | 1 |
| 817 | mn-o-mn | 1 |
| 818 | modality-session | 1 |
| 819 | modality-time | 1 |
| 820 | mode-physician | 1 |
| 821 | moderator-by-treatment | 1 |
| 822 | mode×intensity | 1 |
| 823 | molecule-biomacromolecule | 1 |
| 824 | mor/morip | 1 |
| 825 | more-than-additive | 1 |
| 826 | mother-calf | 1 |
| 827 | mrna-microrna | 1 |
| 828 | myh/ape1 | 1 |
| 829 | myopia-related | 1 |
| 830 | n-ts | 1 |
| 831 | n-v | 1 |
| 832 | nanoparticle-polymer | 1 |
| 833 | nanoparticle-protein | 1 |
| 834 | nanoparticle-tumor | 1 |
| 835 | neurotopic | 1 |
| 836 | nfs1-isu | 1 |
| 837 | nf→σ | 1 |
| 838 | nicotine-paraquat | 1 |
| 839 | nicotine-stimulant | 1 |
| 840 | no-ras | 1 |
| 841 | non-adsorption | 1 |
| 842 | non-dichotomous | 1 |
| 843 | non-nearest-neighbor | 1 |
| 844 | non-redundant-exclusion | 1 |
| 845 | nonsmoking/propranolol | 1 |
| 846 | nox4/mkp-3 | 1 |
| 847 | nucleo-cytoskeleton | 1 |
| 848 | nutrient-exercise | 1 |
| 849 | nutrient/hab | 1 |
| 850 | o-hn | 1 |
| 851 | o-h···nh2 | 1 |
| 852 | o3-temperature | 1 |
| 853 | o5'-h···n3 | 1 |
| 854 | obesity-by-exercise | 1 |
| 855 | object-action | 1 |
| 856 | occasion-amputee | 1 |
| 857 | occlusion-related | 1 |
| 858 | oestrogen-ras | 1 |
| 859 | ofc-amygdala | 1 |
| 860 | oil-food | 1 |
| 861 | onfounding | 1 |
| 862 | operators/analysers | 1 |
| 863 | osa×treatment | 1 |
| 864 | overriding/trade-off | 1 |
| 865 | ox40/ox40l | 1 |
| 866 | p-thpp-hb | 1 |
| 867 | p53/14-3-3σ | 1 |
| 868 | pa-pb1-ipo5 | 1 |
| 869 | pabp-ars | 1 |
| 870 | parasite-vector | 1 |
| 871 | particle-tissue | 1 |
| 872 | pcsk9-ldl-r | 1 |
| 873 | pcsk9/ldlr | 1 |
| 874 | peptide-in-groove | 1 |
| 875 | perindoprilmethamphetamine | 1 |
| 876 | peritransplantational | 1 |
| 877 | person-by-treatment | 1 |
| 878 | pharmacodynamic-kinetic | 1 |
| 879 | pharmacological-independent | 1 |
| 880 | pharmacotherapist-patient | 1 |
| 881 | phenolic-casein | 1 |
| 882 | physician-student | 1 |
| 883 | phytate-zn | 1 |
| 884 | phytoplankton-bacteria | 1 |
| 885 | phytoplasma-host | 1 |
| 886 | pi*z-by-smoking | 1 |
| 887 | pioglitazone-by-rt | 1 |
| 888 | pip2-channel | 1 |
| 889 | placebo-type | 1 |
| 890 | plant-fungal | 1 |
| 891 | plant-microorganism | 1 |
| 892 | plant-nto | 1 |
| 893 | plant-phytoplasma | 1 |
| 894 | plant-symbiont | 1 |
| 895 | platelet-endothelium | 1 |
| 896 | platelet-microvasculature | 1 |
| 897 | pmhc-tcr | 1 |
| 898 | pmn-epithelial | 1 |
| 899 | pnictogen-chalcogen | 1 |
| 900 | pollutant-temperature | 1 |
| 901 | polymorphism-drug | 1 |
| 902 | porphyrin-substrate | 1 |
| 903 | post-cement | 1 |
| 904 | pp2a-ppmt-1 | 1 |
| 905 | predictor×group | 1 |
| 906 | preload-exercise | 1 |
| 907 | previous-trial | 1 |
| 908 | product-subject | 1 |
| 909 | product/surface | 1 |
| 910 | product/time | 1 |
| 911 | proline/g-quartet | 1 |
| 912 | prosody-syntax | 1 |
| 913 | protein-additive | 1 |
| 914 | protein-flavor | 1 |
| 915 | protein-membrane | 1 |
| 916 | protein-metabolite | 1 |
| 917 | protein-polyanion | 1 |
| 918 | protein-protein/dna | 1 |
| 919 | protein-saccharide | 1 |
| 920 | protein–protein | 1 |
| 921 | proteome-diet | 1 |
| 922 | protist-bacterial | 1 |
| 923 | provider-by-group-by-time | 1 |
| 924 | provider-physician | 1 |
| 925 | pseudo-jahn-teller | 1 |
| 926 | psychosocial/spiritual | 1 |
| 927 | pt/vacancy | 1 |
| 928 | pulmonary-cardiac | 1 |
| 929 | py-zeolite | 1 |
| 930 | qtl-by-environment | 1 |
| 931 | quasi-phase-matching | 1 |
| 932 | quercetin-drug | 1 |
| 933 | race-by-amlodipine/lisinopril | 1 |
| 934 | race-by-lisinopril/chlorthalidone | 1 |
| 935 | race-drug | 1 |
| 936 | race-fai | 1 |
| 937 | radiation-drug | 1 |
| 938 | ram-by-extender | 1 |
| 939 | rbp4-ttr | 1 |
| 940 | receptor-sulfate | 1 |
| 941 | regulator-promoter | 1 |
| 942 | reported.subgroup | 1 |
| 943 | researcher-provider | 1 |
| 944 | resilience-abuse | 1 |
| 945 | response-prediction | 1 |
| 946 | resveratrol-drug | 1 |
| 947 | retention-interval | 1 |
| 948 | reward-cognition | 1 |
| 949 | ribotoxin-lipid | 1 |
| 950 | rna-ago2 | 1 |
| 951 | routinise | 1 |
| 952 | rtms-laterality | 1 |
| 953 | rtpa-by-variable | 1 |
| 954 | rubber-filler | 1 |
| 955 | rubber-rubber | 1 |
| 956 | rwa-wheat | 1 |
| 957 | s-h·π | 1 |
| 958 | safety-influencing | 1 |
| 959 | sah-related | 1 |
| 960 | sbd-substrate | 1 |
| 961 | sdf-1α-cxcr4 | 1 |
| 962 | seca/membrane | 1 |
| 963 | sept-ap | 1 |
| 964 | ser19-phosphorylation-dependent | 1 |
| 965 | serotonin-glutamate | 1 |
| 966 | session-time | 1 |
| 967 | sex-age-treatment | 1 |
| 968 | sex-by-correlate | 1 |
| 969 | sex-by-drug | 1 |
| 970 | sex-by-supplement | 1 |
| 971 | sex-by-tstv | 1 |
| 972 | sex-partner | 1 |
| 973 | sex×time | 1 |
| 974 | sex×treatment | 1 |
| 975 | se···o | 1 |
| 976 | se···o/n | 1 |
| 977 | sgf14-gmmyb176 | 1 |
| 978 | shcbt-by-time | 1 |
| 979 | shoot-root | 1 |
| 980 | side-chain-main-chain | 1 |
| 981 | simvastatin-diltiazem | 1 |
| 982 | site-by-treatment-by-time | 1 |
| 983 | site-site | 1 |
| 984 | sleep-pain | 1 |
| 985 | smoking-selenium | 1 |
| 986 | snp-by-sex | 1 |
| 987 | snp-by-time | 1 |
| 988 | society-forest | 1 |
| 989 | solvent-1,2,3-trz | 1 |
| 990 | soybean-pathogen | 1 |
| 991 | species-pathogen | 1 |
| 992 | spin–orbit | 1 |
| 993 | staff-consumer | 1 |
| 994 | staff-resident | 1 |
| 995 | staff-to-staff | 1 |
| 996 | stas-stas | 1 |
| 997 | std-hiv | 1 |
| 998 | stent-type-by-treatment | 1 |
| 999 | steroid-inflammasome | 1 |
| 1000 | strain-by-drug | 1 |
| 1001 | strain×diet | 1 |
| 1002 | stress-alcohol | 1 |
| 1003 | subgroup-by-therapy | 1 |
| 1004 | subgroup-treatment | 1 |
| 1005 | subgroup×time | 1 |
| 1006 | substrate-lipase | 1 |
| 1007 | supervisor-trainee | 1 |
| 1008 | supplement-supplement | 1 |
| 1009 | supplement/time | 1 |
| 1010 | support-metal | 1 |
| 1011 | surgery-by-treatment | 1 |
| 1012 | sweetener-drug | 1 |
| 1013 | synaptopodin/14-3-3β | 1 |
| 1014 | synergistic/antagonistic/suppressing | 1 |
| 1015 | syntax-prosody | 1 |
| 1016 | synthetic-genetic | 1 |
| 1017 | s···n/s | 1 |
| 1018 | tactile-pain | 1 |
| 1019 | tak1/tab2 | 1 |
| 1020 | tamoxifen/norfloxacin | 1 |
| 1021 | tds×medication | 1 |
| 1022 | tec-thymocyte | 1 |
| 1023 | te⋯o | 1 |
| 1024 | tf's-target | 1 |
| 1025 | tf-dna | 1 |
| 1026 | tfap2b-macronutrient | 1 |
| 1027 | th-cell | 1 |
| 1028 | th-partner | 1 |
| 1029 | thc-ache | 1 |
| 1030 | therapist-subject | 1 |
| 1031 | therapy-by-age | 1 |
| 1032 | therapy-by-time | 1 |
| 1033 | thiol-mediated | 1 |
| 1034 | thujopsene-drug | 1 |
| 1035 | thyroid-catecholamine | 1 |
| 1036 | tick-rickettsia | 1 |
| 1037 | time-by-stratum | 1 |
| 1038 | time-covariate | 1 |
| 1039 | time-dca | 1 |
| 1040 | time-gender | 1 |
| 1041 | time-of-entry | 1 |
| 1042 | time-survival | 1 |
| 1043 | time×meal | 1 |
| 1044 | time×trial | 1 |
| 1045 | tl1a-dr3 | 1 |
| 1046 | tlr-4-rwmhsp60 | 1 |
| 1047 | tnf-alpha-tnf-receptor | 1 |
| 1048 | tnf-il-1 | 1 |
| 1049 | tomato-oil | 1 |
| 1050 | top/cm | 1 |
| 1051 | toxin-channel | 1 |
| 1052 | tradic | 1 |
| 1053 | trainee-supervisor | 1 |
| 1054 | trait-task | 1 |
| 1055 | trauma-by-treatment-by-time | 1 |
| 1056 | treatment-baseline | 1 |
| 1057 | treatment-by-anxiety | 1 |
| 1058 | treatment-by-clinic | 1 |
| 1059 | treatment-by-diagnosis | 1 |
| 1060 | treatment-by-ed-status | 1 |
| 1061 | treatment-by-investigator | 1 |
| 1062 | treatment-by-lesion-size | 1 |
| 1063 | treatment-by-period | 1 |
| 1064 | treatment-by-strata-by-time | 1 |
| 1065 | treatment-by-stratum | 1 |
| 1066 | treatment-by-visit | 1 |
| 1067 | treatment-by-weight | 1 |
| 1068 | treatment-gene | 1 |
| 1069 | treatment-genotype | 1 |
| 1070 | treatment-marker | 1 |
| 1071 | treatment-polymorphism | 1 |
| 1072 | treatment-to-time | 1 |
| 1073 | treatment×cs | 1 |
| 1074 | trp-lipid | 1 |
| 1075 | trp159-asp126 | 1 |
| 1076 | tslp-tslpr | 1 |
| 1077 | tumor-vascular | 1 |
| 1078 | tumor/bone | 1 |
| 1079 | u-c | 1 |
| 1080 | u2af-rna | 1 |
| 1081 | udca-haplotype | 1 |
| 1082 | unmeasured/unobserved | 1 |
| 1083 | upf1-rna | 1 |
| 1084 | ura2-hsp90 | 1 |
| 1085 | user-device | 1 |
| 1086 | varenicline-drug | 1 |
| 1087 | variable-by-treatment | 1 |
| 1088 | vas-genotype | 1 |
| 1089 | ventricular-valve | 1 |
| 1090 | vildagliptin-dpp-4 | 1 |
| 1091 | viral-host | 1 |
| 1092 | virus-bacterial-host | 1 |
| 1093 | visit-by-treatment | 1 |
| 1094 | visual-nociceptive | 1 |
| 1095 | vwf-galectin | 1 |
| 1096 | warfarin-fluconazole | 1 |
| 1097 | warfarin-levofloxacin | 1 |
| 1098 | water-fa | 1 |
| 1099 | water-hydrocarbon | 1 |
| 1100 | water-rock | 1 |
| 1101 | wm-attention | 1 |
| 1102 | ximelagatran-erythromycin | 1 |
| 1103 | xylan-cellulose | 1 |
| 1104 | yl.chn1p/ssa1p | 1 |
| 1105 | zns-pmma | 1 |
| 1106 | zooplankton-cyanobacteria | 1 |
| 1107 | β2/14-3-3-ζ | 1 |
| 1108 | δglucose×gender | 1 |
| 1109 | π-ring⋯carbon-yl | 1 |
| 1 | -by-time | 1 |
| 2 | -enzyme | 1 |
| 3 | -glycan | 1 |
| 4 | -lacy | 1 |
| 5 | -ph···co | 1 |
| 6 | -ph···cr | 1 |
| 7 | /hsp90 | 1 |
| 8 | /kaiso | 1 |
| 9 | /membrane | 1 |
| 10 | /p23 | 2 |
| 11 | /rhoa | 1 |
| 12 | 1,3-equatorial | 1 |
| 13 | 1,3-syn-axial | 1 |
| 14 | 14-3-3/cby | 2 |
| 15 | 14-3-3/client | 1 |
| 16 | 14-3-3ɛ-vdac1 | 1 |
| 17 | 14-3-3ζ-client | 1 |
| 18 | 14-3-3ζ-ezrin | 1 |
| 19 | 14-3-3ζ-phosphoprotein | 1 |
| 20 | 14-3-3ζ/gabab1 | 1 |
| 21 | 3'-bte-5'-utr | 1 |
| 22 | 32-core | 1 |
| 23 | 5-hmf-hsa/bsa | 1 |
| 24 | a-minor | 1 |
| 25 | aba-hsp70 | 2 |
| 26 | acd-cam | 2 |
| 27 | actin-arp2/3 | 1 |
| 28 | actin-myosin | 11 |
| 29 | activity-treatment | 1 |
| 30 | actor-partner | 5 |
| 31 | additivity/indifference | 1 |
| 32 | adipor1/cav-3 | 2 |
| 33 | adsorbate-adsorbate | 1 |
| 34 | aea-hsp | 1 |
| 35 | aetiopathogenetic | 5 |
| 36 | aetiopathogenic | 2 |
| 37 | affinity-like | 1 |
| 38 | ag-ligand | 1 |
| 39 | age-by-gender | 1 |
| 40 | age-by-gender-by-framing | 1 |
| 41 | age-by-gender-by-treatment | 1 |
| 42 | age-by-sex | 2 |
| 43 | age-by-treatment | 5 |
| 44 | age-drug | 1 |
| 45 | age-rasagiline | 1 |
| 46 | age-smoking | 1 |
| 47 | age-treatment | 2 |
| 48 | agency-structure | 1 |
| 49 | aggravating | 113 |
| 50 | agmatine-cannabinoid | 1 |
| 51 | ag⋯f | 3 |
| 52 | air-sea | 4 |
| 53 | al-au-al/b-au-al | 2 |
| 54 | al-c | 1 |
| 55 | aldolase-actin | 1 |
| 56 | alterable | 5 |
| 57 | amblyogenic | 8 |
| 58 | amine-water | 1 |
| 59 | ammonium-quartz | 1 |
| 60 | amyloid-tau | 2 |
| 61 | angio-associated | 1 |
| 62 | animal-born | 1 |
| 63 | animal-fluid | 1 |
| 64 | anion-anion | 2 |
| 65 | anion-π | 6 |
| 66 | anti-malarial-anti-retroviral | 1 |
| 67 | anti-tnp/tnp | 1 |
| 68 | antibiotic-drug | 1 |
| 69 | antibody-pathogen | 1 |
| 70 | antibody/toxin | 1 |
| 71 | antiferro-magnetic | 3 |
| 72 | antiperiplanar | 1 |
| 73 | ap-3-clathrin | 2 |
| 74 | apelin/receptor | 1 |
| 75 | api/polymer | 1 |
| 76 | apolipoprotein-cell | 1 |
| 77 | aptitude-treatment | 5 |
| 78 | arene-perfluoroarene | 2 |
| 79 | argentophilic | 1 |
| 80 | arginine-arene | 2 |
| 81 | arms-by-visits | 1 |
| 82 | aromatic-aromatic | 1 |
| 83 | aromatic-ring | 1 |
| 84 | arsenic/cadmium | 2 |
| 85 | arterial-heart | 1 |
| 86 | artn-gfrα3 | 1 |
| 87 | as/14-3-3η | 2 |
| 88 | assessment-based | 8 |
| 89 | atg14l-vps34/vps15 | 2 |
| 90 | attribute-treatment | 3 |
| 91 | au-au | 2 |
| 92 | au-mn | 1 |
| 93 | auditory-to-motor | 1 |
| 94 | aurophilic | 11 |
| 95 | au···au | 1 |
| 96 | ay23-trypsin | 1 |
| 97 | bacteria-host | 2 |
| 98 | bacteria-immune | 1 |
| 99 | bacteria-uc | 1 |
| 100 | bacterial/hab | 1 |
| 101 | base-phosphate | 1 |
| 102 | baseline-by-treatment | 6 |
| 103 | bcl2-becn1 | 1 |
| 104 | between-ed-subgroup | 1 |
| 105 | between-language | 1 |
| 106 | birds/human | 1 |
| 107 | bjp-thp | 1 |
| 108 | blood-material | 1 |
| 109 | blood-membrane | 1 |
| 110 | blood-surface | 1 |
| 111 | blood-tissue | 4 |
| 112 | blood-valve | 1 |
| 113 | bmd-related | 1 |
| 114 | bmi*diet | 1 |
| 115 | botanical-drug | 1 |
| 116 | both-through | 1 |
| 117 | brain-catecholamine | 1 |
| 118 | br⋯n | 1 |
| 119 | br⋯ometh-oxy | 1 |
| 120 | br⋯onitro | 1 |
| 121 | bubble-bubble | 1 |
| 122 | bullxtreatment | 1 |
| 123 | bbmn | 1 |
| 124 | c-h···ti | 1 |
| 125 | c-h···π | 16 |
| 126 | c-h⋯ocarbon-yl | 2 |
| 127 | c-h⋯π | 93 |
| 128 | c6-b | 1 |
| 129 | c60-water | 1 |
| 130 | c=o⋯π | 1 |
| 131 | caf-epithelial | 1 |
| 132 | caffeine-extraversion | 1 |
| 133 | caffeine-haemoglobin | 1 |
| 134 | calcium-iron | 1 |
| 135 | capase-3/calbindin-d28k | 1 |
| 136 | carbohydrate-lectin | 1 |
| 137 | carbon-substituted | 1 |
| 138 | carbonyl-carbonyl | 1 |
| 139 | cardiac/noncardiac | 1 |
| 140 | caries-related | 5 |
| 141 | carom-h⋯o | 1 |
| 142 | casa-derived | 1 |
| 143 | case-mix | 56 |
| 144 | caseworker-recipient | 1 |
| 145 | catalase-amyloid | 4 |
| 146 | catalase-aβ | 1 |
| 147 | category-comprising | 1 |
| 148 | cation-cation | 5 |
| 149 | cation-pi | 1 |
| 150 | cation-π | 5 |
| 151 | cb1/trpv1 | 1 |
| 152 | cb2/hsp90 | 1 |
| 153 | ccna2-drug | 1 |
| 154 | ccr4-ligand | 1 |
| 155 | cc⋯ho | 1 |
| 156 | cd28/b7 | 1 |
| 157 | cd40/cd154 | 1 |
| 158 | cell-apolipoprotein | 1 |
| 159 | cell-cell-mediated | 1 |
| 160 | cell-ecm | 2 |
| 161 | cell/phbhhx-l | 1 |
| 162 | cell/surface | 1 |
| 163 | cell–matrix | 1 |
| 164 | center-surround | 1 |
| 165 | centre-treatment | 1 |
| 166 | chemical-protein | 4 |
| 167 | chemo-biological | 1 |
| 168 | chias | 4 |
| 169 | child-family | 1 |
| 170 | child-robot | 1 |
| 171 | cholinoreceptor | 1 |
| 172 | chp-drug | 1 |
| 173 | ch···o | 2 |
| 174 | ch₃cn-ch₃cn | 1 |
| 175 | ch⋯π | 1 |
| 176 | cl-s | 1 |
| 177 | client-professional | 1 |
| 178 | clinician‒patient | 1 |
| 179 | clinicoroentgenological | 1 |
| 180 | clopidogrel-drug | 1 |
| 181 | clopidogrel-ppi | 1 |
| 182 | cloud-aerosol | 1 |
| 183 | cluster-defining | 1 |
| 184 | cl⋅⋅⋅c | 1 |
| 185 | co-surface | 1 |
| 186 | co-variate | 5 |
| 187 | co2-zeolite | 1 |
| 188 | coach-patient | 1 |
| 189 | coaggregative | 1 |
| 190 | colah-collagen | 1 |
| 191 | commensal-immune | 1 |
| 192 | complexity-by-intervention | 1 |
| 193 | compliance-treatment | 2 |
| 194 | condition-by-education | 1 |
| 195 | condition-by-time | 10 |
| 196 | condition-time | 1 |
| 197 | condition/time | 1 |
| 198 | condition×sequence | 1 |
| 199 | condition×time | 2 |
| 200 | confounder | 96 |
| 201 | confounder-exposure | 1 |
| 202 | confounding | 2,243 |
| 203 | contributory | 149 |
| 204 | copper-prion | 1 |
| 205 | copper-selenium | 1 |
| 206 | coral-cca | 1 |
| 207 | coral-turf | 1 |
| 208 | core/electron-electron | 1 |
| 209 | coronavirus-receptor | 1 |
| 210 | corticosteroid-herb | 1 |
| 211 | corticosteroid-licorice | 1 |
| 212 | cost-driving | 1 |
| 213 | coulombian | 1 |
| 214 | coupling/decoupling | 1 |
| 215 | covariable | 14 |
| 216 | covariate | 1,011 |
| 217 | covariate-by-treatment | 1 |
| 218 | covariate-treatment | 4 |
| 219 | cp-hsp70 | 1 |
| 220 | cpc7 | 2 |
| 221 | cpox4-hg | 1 |
| 222 | cpr6-hsp90 | 1 |
| 223 | cpsf-aauaaa | 1 |
| 224 | cpsf30-rna | 1 |
| 225 | cross-exon | 1 |
| 226 | cross-level | 6 |
| 227 | cross-partner | 3 |
| 228 | crown-to-crown | 1 |
| 229 | crp-drug | 1 |
| 230 | csa-isoprenaline | 1 |
| 231 | csa-β-adrenoceptor | 1 |
| 232 | cta1-chaperone | 1 |
| 233 | ctx-upa/pai-1 | 1 |
| 234 | cuprophilic | 3 |
| 235 | cx43-hsc70 | 1 |
| 236 | cyanophage-host | 1 |
| 237 | database/target | 1 |
| 238 | day*energy | 1 |
| 239 | day×gel | 1 |
| 240 | dbc1-sirt1 | 2 |
| 241 | ddx3-irf3 | 1 |
| 242 | depression-by-ptsd | 1 |
| 243 | device-device | 1 |
| 244 | device-drug | 1 |
| 245 | dexamethasone/aprepitant | 1 |
| 246 | diabetic-disease | 1 |
| 247 | diagnosis×time | 2 |
| 248 | dicer1-p-smad2/3 | 1 |
| 249 | diet-drug | 4 |
| 250 | diet-gene | 5 |
| 251 | diet-genotype | 1 |
| 252 | diet-microbiota | 1 |
| 253 | diet-time | 1 |
| 254 | digoxin-gender | 1 |
| 255 | dimer-substrate | 1 |
| 256 | diphylla-insect | 1 |
| 257 | dipole-dipole | 22 |
| 258 | dipole-quadruple | 1 |
| 259 | dipole-quadrupole | 9 |
| 260 | disease-target | 1 |
| 261 | disulfiram-chloral | 1 |
| 262 | dll4-notch1 | 1 |
| 263 | dna-drug | 1 |
| 264 | dna-ligand | 1 |
| 265 | dna-protein | 9 |
| 266 | dnaa-oric | 1 |
| 267 | doctor-parent | 1 |
| 268 | dopamine/dmpg | 1 |
| 269 | dose-by-time | 1 |
| 270 | dose-form | 1 |
| 271 | dromotropic | 2 |
| 272 | dronedarone-digoxin | 1 |
| 273 | drug-alcohol | 3 |
| 274 | drug-bilirubin | 1 |
| 275 | drug-by-age | 1 |
| 276 | drug-by-predictor | 1 |
| 277 | drug-by-time | 3 |
| 278 | drug-cam | 1 |
| 279 | drug-cell | 2 |
| 280 | drug-channel | 1 |
| 281 | drug-cranberry | 1 |
| 282 | drug-disease | 34 |
| 283 | drug-drug | 510 |
| 284 | drug-enzyme | 1 |
| 285 | drug-excipient | 5 |
| 286 | drug-excipients | 1 |
| 287 | drug-flavonoid | 1 |
| 288 | drug-food | 19 |
| 289 | drug-gene | 1 |
| 290 | drug-herb | 33 |
| 291 | drug-herb/herb-herb | 1 |
| 292 | drug-herbs | 1 |
| 293 | drug-laboratory | 3 |
| 294 | drug-membrane | 2 |
| 295 | drug-metabolite | 1 |
| 296 | drug-micronutrient | 1 |
| 297 | drug-milk | 1 |
| 298 | drug-nutrient | 4 |
| 299 | drug-organism | 1 |
| 300 | drug-personality | 1 |
| 301 | drug-pregnancy | 1 |
| 302 | drug-receptor | 5 |
| 303 | drug-statin | 7 |
| 304 | drug-steroid | 1 |
| 305 | drug-supplement | 5 |
| 306 | drug-target | 11 |
| 307 | drug-to-drug | 7 |
| 308 | drug-vitamin-herbal | 1 |
| 309 | drug/disease | 1 |
| 310 | drug/t1301 | 1 |
| 311 | drug×time | 1 |
| 312 | drug–drug | 1 |
| 313 | drug–food | 1 |
| 314 | ds-drug | 1 |
| 315 | dye-light | 1 |
| 316 | dzyaloshinskii-moriya | 1 |
| 317 | ebs3-ibs3 | 1 |
| 318 | edge-to-face | 5 |
| 319 | effect-covariate | 1 |
| 320 | effect-modifying | 9 |
| 321 | efficiency-property-pharmacology-target-protein | 1 |
| 322 | egcg-bsa | 1 |
| 323 | electron-vibration | 2 |
| 324 | eliminable | 1 |
| 325 | emerged-medicinal | 1 |
| 326 | emotion-cognition | 2 |
| 327 | empathy×content | 1 |
| 328 | encephalographic | 3 |
| 329 | end-orientation | 1 |
| 330 | endocardial-endothelial/cardiomyocyte | 1 |
| 331 | endocrine-immune-paracrine | 1 |
| 332 | endothelin-ra | 1 |
| 333 | energy-by-protein | 1 |
| 334 | environment-behavior | 1 |
| 335 | environment-speed | 2 |
| 336 | enzyme-drug | 1 |
| 337 | enzyme-ligand | 4 |
| 338 | epinephrine/hypertensive | 1 |
| 339 | epistatic | 27 |
| 340 | epistatic-environmental-biological | 1 |
| 341 | epithelial-bacterial | 1 |
| 342 | epithelial-stromal | 5 |
| 343 | epithelium-gamete | 1 |
| 344 | er-level | 1 |
| 345 | er-striatin | 1 |
| 346 | erα/14-3-3 | 3 |
| 347 | erα/chromatin | 1 |
| 348 | estrogen-serotonin | 1 |
| 349 | estrogen-stress | 1 |
| 350 | ethnicity-by-education | 1 |
| 351 | ethnicity-by-ep | 1 |
| 352 | etra/etrb | 1 |
| 353 | excluded-volume | 2 |
| 354 | exercise-nutrient | 1 |
| 355 | expectations-realization | 1 |
| 356 | explanatory | 618 |
| 357 | fab-fab | 1 |
| 358 | fat-carbohydrate | 1 |
| 359 | fe-o-mn | 2 |
| 360 | feedback-this | 1 |
| 361 | filler-rubber | 1 |
| 362 | flavonoid-abc-transporter | 1 |
| 363 | flory | 1 |
| 364 | fluid-structure | 6 |
| 365 | food-by-dose | 1 |
| 366 | food-drug | 12 |
| 367 | food-web | 1 |
| 368 | four-body | 1 |
| 369 | fpr-specific | 1 |
| 370 | framingham-based | 4 |
| 371 | fronte | 2 |
| 372 | fröhlich | 1 |
| 373 | fullerene-water | 1 |
| 374 | fungal/crop/environment | 1 |
| 375 | fungus-host | 1 |
| 376 | fungus-insect | 1 |
| 377 | gal-3-inhibitor | 2 |
| 378 | gal-3/bax | 1 |
| 379 | gal-3/gal-3 | 1 |
| 380 | galectin-3/polylacnac | 1 |
| 381 | gas-surface | 4 |
| 382 | gas-wall | 2 |
| 383 | gas/surface | 2 |
| 384 | gastrointestinal-respiratory | 1 |
| 385 | gch1-chip | 1 |
| 386 | gemfibrozil-repaglinide | 1 |
| 387 | gender-by-diagnosis | 1 |
| 388 | gender-by-lisinopril/amlodipine | 1 |
| 389 | gender-by-race | 1 |
| 390 | gender-cue | 1 |
| 391 | gender-drug | 1 |
| 392 | gender-gene | 1 |
| 393 | gender-to-diet | 1 |
| 394 | gender-treatment | 2 |
| 395 | gender/lithium | 1 |
| 396 | gender×condition | 1 |
| 397 | gender×mets | 1 |
| 398 | gene*diet | 1 |
| 399 | gene-b-vitamin | 1 |
| 400 | gene-by-dose | 2 |
| 401 | gene-by-environment | 9 |
| 402 | gene-by-flavonoid | 1 |
| 403 | gene-by-gender | 1 |
| 404 | gene-by-sex | 1 |
| 405 | gene-by-smoking | 2 |
| 406 | gene-by-treatment | 3 |
| 407 | gene-concentration | 1 |
| 408 | gene-diet | 26 |
| 409 | gene-drug | 7 |
| 410 | gene-environment | 72 |
| 411 | gene-gene | 44 |
| 412 | gene-lifestyle | 2 |
| 413 | gene-nutrient | 4 |
| 414 | gene-nutritional | 1 |
| 415 | gene-smoking | 1 |
| 416 | gene-treatment | 6 |
| 417 | gene/environment | 4 |
| 418 | genes/environment | 4 |
| 419 | genetic-environment | 1 |
| 420 | genetic/environment | 1 |
| 421 | gene×environment | 2 |
| 422 | gene×gene | 1 |
| 423 | genome-environment | 1 |
| 424 | genotype-by-diagnosis | 2 |
| 425 | genotype-by-environment | 1 |
| 426 | genotype-by-intervention | 2 |
| 427 | genotype-by-sex | 1 |
| 428 | genotype-by-time | 1 |
| 429 | genotype-by-treatment | 4 |
| 430 | genotype-genotype | 1 |
| 431 | genotype-intervention | 1 |
| 432 | genotype-time | 1 |
| 433 | genotype-treatment | 4 |
| 434 | genotype/drug | 1 |
| 435 | genotype/treatment | 1 |
| 436 | gesture-based | 1 |
| 437 | gfj-drug | 1 |
| 438 | gfj-fexofenadine | 1 |
| 439 | gfj-loperamide | 1 |
| 440 | gh14-3-3-ghbzr1 | 1 |
| 441 | glap-rage | 1 |
| 442 | glycan-glycan | 1 |
| 443 | glycan-lectin | 1 |
| 444 | gonadotrophin-dose | 1 |
| 445 | gp120-cd4 | 1 |
| 446 | gpr30-ramp3 | 1 |
| 447 | gpr43-scfa | 1 |
| 448 | group*session | 2 |
| 449 | group*weeks | 1 |
| 450 | group-by-age | 1 |
| 451 | group-by-emotion | 2 |
| 452 | group-by-sex | 1 |
| 453 | group-by-soc | 1 |
| 454 | group-by-speed | 1 |
| 455 | group-by-stage | 1 |
| 456 | group-by-task | 1 |
| 457 | group-by-time | 151 |
| 458 | group-by-time-by-arm | 1 |
| 459 | group-by-visit | 1 |
| 460 | group-region | 1 |
| 461 | group-time | 12 |
| 462 | group-x-time | 2 |
| 463 | groups*period | 1 |
| 464 | group×load×time | 1 |
| 465 | group×time | 45 |
| 466 | group×time×education | 1 |
| 467 | group×time×grade | 2 |
| 468 | group×time×sex | 3 |
| 469 | growth/inhibitory | 1 |
| 470 | gsk-3-shared | 1 |
| 471 | guanine-zno | 1 |
| 472 | guideline-level | 1 |
| 473 | g×e | 1 |
| 474 | g×t | 2 |
| 475 | h-bonding | 28 |
| 476 | h3.3k36me3/bs69 | 1 |
| 477 | ha-glycan | 2 |
| 478 | haeme-protein | 1 |
| 479 | halogen-halogen | 2 |
| 480 | haplotype-drug | 1 |
| 481 | hb101-uc | 1 |
| 482 | hba1c/ethnicity | 1 |
| 483 | hbd-3-cxcr4 | 1 |
| 484 | hcv-host | 2 |
| 485 | head-rod | 1 |
| 486 | heat-exacerbating | 1 |
| 487 | heme-ligand | 2 |
| 488 | her2/her3 | 1 |
| 489 | herb-drug | 96 |
| 490 | herb-herb | 14 |
| 491 | herbal-drug | 7 |
| 492 | herbdrug | 1 |
| 493 | herbs-drugs | 1 |
| 494 | hg-drug | 1 |
| 495 | high-friction | 2 |
| 496 | higher-body | 1 |
| 497 | histology-by-treatment | 2 |
| 498 | histone-protein | 1 |
| 499 | hn-f | 1 |
| 500 | hn-receptor | 1 |
| 501 | hnrnpk-dna | 1 |
| 502 | homocysteine-gene | 1 |
| 503 | hormone-brain-behavior | 1 |
| 504 | host-agent | 1 |
| 505 | host-bacteria | 3 |
| 506 | host-donor | 1 |
| 507 | host-fungus | 2 |
| 508 | host-host | 1 |
| 509 | host-microbe | 15 |
| 510 | host-microbial | 5 |
| 511 | host-microflora | 1 |
| 512 | host-organism | 2 |
| 513 | host-parasitoid | 3 |
| 514 | host-pathogen | 38 |
| 515 | host-pathogens | 1 |
| 516 | host-virus | 4 |
| 517 | host/guest | 1 |
| 518 | host/pathogen | 1 |
| 519 | host∶parasite | 1 |
| 520 | hsf1/dhse | 1 |
| 521 | hsp-receptor | 1 |
| 522 | hsp20-pde4d | 1 |
| 523 | hsp27/tlr3 | 1 |
| 524 | hsp70-hla-dr | 1 |
| 525 | hsp90-gch1 | 3 |
| 526 | hsp90-inrf2 | 3 |
| 527 | hsp90/cdc37 | 1 |
| 528 | hsp90/gch1 | 1 |
| 529 | hsp90β/p23 | 1 |
| 530 | human-forest | 1 |
| 531 | human-microbe | 2 |
| 532 | human-raccoon | 1 |
| 533 | human-robot | 6 |
| 534 | human/environment | 1 |
| 535 | human/environmental/cultural | 1 |
| 536 | hydrogen-bond-like | 3 |
| 537 | hydrogen-bonding | 85 |
| 538 | hyper-conjugative | 22 |
| 539 | hyperconjucative | 1 |
| 540 | hyperconjugative | 15 |
| 541 | h···cl | 1 |
| 542 | ibuprofen/aspirin | 1 |
| 543 | icd/drug | 1 |
| 544 | ih901-training | 1 |
| 545 | in-tnpo3 | 1 |
| 546 | inducer-receptor | 1 |
| 547 | industry-physician | 1 |
| 548 | infant/parent | 1 |
| 549 | influenceable | 2 |
| 550 | infusion-rates | 1 |
| 551 | initiator-oric | 1 |
| 552 | initiator-origin | 1 |
| 553 | insect-pathogen | 1 |
| 554 | intake-producer | 1 |
| 555 | integrin-kindlin-3 | 3 |
| 556 | integrin-toxin | 1 |
| 557 | inter-chromosomal | 1 |
| 558 | inter-collegial | 1 |
| 559 | inter-herbal | 1 |
| 560 | inter-moiety | 1 |
| 561 | inter-sexual | 2 |
| 562 | inter-trimer | 1 |
| 563 | interologous | 1 |
| 564 | interpeptide | 2 |
| 565 | interracial | 7 |
| 566 | intervention*age | 1 |
| 567 | intervention-by-age | 1 |
| 568 | intetumumab-dacarbazine | 1 |
| 569 | intra-herb | 1 |
| 570 | intra-layer | 1 |
| 571 | intra-sensory | 2 |
| 572 | intra-solvent | 1 |
| 573 | intramyotubularin | 1 |
| 574 | inv-integrin | 1 |
| 575 | ion-matter | 1 |
| 576 | iop-independent | 2 |
| 577 | ipaf-macrophage | 1 |
| 578 | irf3/ikkβ | 1 |
| 579 | item-unspecific | 1 |
| 580 | ki-drug | 1 |
| 581 | kif23-14-3-3 | 1 |
| 582 | kindlin-3-β2-integrin | 1 |
| 583 | kissing-loop | 4 |
| 584 | kubas | 1 |
| 585 | laser-matter | 1 |
| 586 | laser-metal | 1 |
| 587 | laser-tissue | 5 |
| 588 | lectin-glycan | 1 |
| 589 | ledgf/p75-in | 1 |
| 590 | lef-3-lef-3 | 1 |
| 591 | lens-solution | 4 |
| 592 | leukocyte-endothelium | 3 |
| 593 | leukocyte-epithelial | 1 |
| 594 | leukocyte-platelet-endothelial | 1 |
| 595 | leukoycte-endothelial | 1 |
| 596 | lfa-3/cd2 | 1 |
| 597 | ligand-core | 1 |
| 598 | ligand-ligand | 4 |
| 599 | ligand-macromolecule | 1 |
| 600 | ligand-target | 6 |
| 601 | light-tissue | 2 |
| 602 | light-water | 1 |
| 603 | lipid-lipid | 1 |
| 604 | lipoprotein-related | 10 |
| 605 | liquorice-herb/drug | 1 |
| 606 | ll-37/dna | 1 |
| 607 | lmir5-c24:1 | 1 |
| 608 | lnk-jak2 | 1 |
| 609 | lo18-membrane | 1 |
| 610 | loading-related | 2 |
| 611 | lumo-lumo | 1 |
| 612 | lung-heart | 3 |
| 613 | lung-kidney | 2 |
| 614 | lvef-by-treatment | 1 |
| 615 | machine-human | 1 |
| 616 | magnetostatic | 1 |
| 617 | many-to-one-by-condition | 1 |
| 618 | marker-treatment | 1 |
| 619 | material-implant | 1 |
| 620 | maternal/offspring | 1 |
| 621 | mb-protein | 1 |
| 622 | md-2/zaa | 1 |
| 623 | mdm2-nucleophosmin | 1 |
| 624 | mdm2-p53 | 3 |
| 625 | mdm2/p53 | 7 |
| 626 | medical/obstetric | 5 |
| 627 | medication-by-time | 1 |
| 628 | medications/drug | 1 |
| 629 | medication×stress×trial | 1 |
| 630 | meevd-tpr | 1 |
| 631 | met-hsp83 | 1 |
| 632 | metabolic-based | 2 |
| 633 | metal-coordinating | 2 |
| 634 | metal-methane | 1 |
| 635 | metal-to-cluster | 1 |
| 636 | metal···π | 1 |
| 637 | metformin×exercise | 1 |
| 638 | methyl-ene-bromo-benzene | 1 |
| 639 | mg-cd | 1 |
| 640 | mg-p | 1 |
| 641 | microalgae/bacteria | 1 |
| 642 | microbe-host | 3 |
| 643 | microbial-host | 1 |
| 644 | microbial-microbial | 1 |
| 645 | microbiota-hormone | 1 |
| 646 | microglial-neuronal | 1 |
| 647 | mind-brain-body | 1 |
| 648 | mirna-mrna | 3 |
| 649 | mirna-target | 1 |
| 650 | mirna/mrna | 2 |
| 651 | mn-o-mn | 1 |
| 652 | modality-session | 1 |
| 653 | modality-time | 1 |
| 654 | mode-physician | 1 |
| 655 | moderator-by-treatment | 1 |
| 656 | mode×intensity | 1 |
| 657 | modifiable | 879 |
| 658 | molecule-biomacromolecule | 1 |
| 659 | molecule-protein | 4 |
| 660 | molecule-substrate | 2 |
| 661 | mor/morip | 1 |
| 662 | more-than-additive | 1 |
| 663 | mother-calf | 1 |
| 664 | mother-children | 2 |
| 665 | mrna-microrna | 1 |
| 666 | mu-9-csap | 2 |
| 667 | myh/ape1 | 1 |
| 668 | myopia-related | 1 |
| 669 | n-h⋯f | 5 |
| 670 | n-ts | 1 |
| 671 | n-v | 1 |
| 672 | nanoparticle-polymer | 1 |
| 673 | nanoparticle-protein | 1 |
| 674 | nanoparticle-tumor | 1 |
| 675 | nature-nurture | 3 |
| 676 | nectin-afadin | 2 |
| 677 | neurotopic | 1 |
| 678 | neutrophil/endothelial | 2 |
| 679 | nfs1-isu | 1 |
| 680 | nf→σ | 1 |
| 681 | nh···o | 4 |
| 682 | nicotine-paraquat | 1 |
| 683 | nicotine-stimulant | 1 |
| 684 | no-ras | 1 |
| 685 | non-adsorption | 1 |
| 686 | non-bonding | 2 |
| 687 | non-dichotomous | 1 |
| 688 | non-modifiable | 20 |
| 689 | non-nearest-neighbor | 1 |
| 690 | non-radiation | 3 |
| 691 | non-redundant-exclusion | 1 |
| 692 | nonbonding | 6 |
| 693 | nonmodifiable | 25 |
| 694 | nonradiation | 4 |
| 695 | nonreciprocal | 3 |
| 696 | nonsmoking/propranolol | 1 |
| 697 | nox4/mkp-3 | 1 |
| 698 | nucleo-cytoskeleton | 1 |
| 699 | nutrient-disease | 2 |
| 700 | nutrient-drug | 4 |
| 701 | nutrient-exercise | 1 |
| 702 | nutrient-gene | 3 |
| 703 | nutrient-nutrient | 3 |
| 704 | nutrient/hab | 1 |
| 705 | o-hn | 1 |
| 706 | o-h···nh2 | 1 |
| 707 | o3-temperature | 1 |
| 708 | o5'-h···n3 | 1 |
| 709 | obesity-by-exercise | 1 |
| 710 | object-action | 1 |
| 711 | occasion-amputee | 1 |
| 712 | occlusion-related | 1 |
| 713 | oestrogen-ras | 1 |
| 714 | ofc-amygdala | 1 |
| 715 | oil-food | 1 |
| 716 | olfactory-visual | 2 |
| 717 | onfounding | 1 |
| 718 | operators/analysers | 1 |
| 719 | organization-level | 2 |
| 720 | osa×treatment | 1 |
| 721 | overriding/trade-off | 1 |
| 722 | overtaking | 2 |
| 723 | ox40/ox40l | 1 |
| 724 | oxygen-temperature | 2 |
| 725 | ozone-heat | 2 |
| 726 | p-thpp-hb | 1 |
| 727 | p311-eif3b | 2 |
| 728 | p53/14-3-3σ | 1 |
| 729 | p53/mdm2 | 2 |
| 730 | pa-pb1-ipo5 | 1 |
| 731 | pabp-ars | 1 |
| 732 | paip1-eif3 | 3 |
| 733 | panic-relevant | 6 |
| 734 | parasite-vector | 1 |
| 735 | parasocial | 3 |
| 736 | parent/infant | 2 |
| 737 | particle-tissue | 1 |
| 738 | pathogen-host | 2 |
| 739 | pcsk9-ldl-r | 1 |
| 740 | pcsk9/ldlr | 1 |
| 741 | peer-client | 2 |
| 742 | peptide-in-groove | 1 |
| 743 | peptide-mediated | 2 |
| 744 | perindoprilmethamphetamine | 1 |
| 745 | peritransplantational | 1 |
| 746 | person-by-treatment | 1 |
| 747 | pharmacodynamic-kinetic | 1 |
| 748 | pharmacological-independent | 1 |
| 749 | pharmacotherapist-patient | 1 |
| 750 | phenolic-casein | 1 |
| 751 | physician-student | 1 |
| 752 | phytate-zn | 1 |
| 753 | phytoplankton-bacteria | 1 |
| 754 | phytoplasma-host | 1 |
| 755 | pi*z-by-smoking | 1 |
| 756 | pi-cation | 3 |
| 757 | pi-pi | 4 |
| 758 | pioglitazone-by-rt | 1 |
| 759 | pip2-channel | 1 |
| 760 | placebo-type | 1 |
| 761 | plant-fungal | 1 |
| 762 | plant-microbe | 3 |
| 763 | plant-microorganism | 1 |
| 764 | plant-nto | 1 |
| 765 | plant-pathogen | 10 |
| 766 | plant-phytoplasma | 1 |
| 767 | plant-symbiont | 1 |
| 768 | plasma-tissue | 2 |
| 769 | plasmon-exciton | 2 |
| 770 | platelet-endothelium | 1 |
| 771 | platelet-microvasculature | 1 |
| 772 | pmhc-tcr | 1 |
| 773 | pmn-epithelial | 1 |
| 774 | pnictogen-chalcogen | 1 |
| 775 | pollen-pistil | 3 |
| 776 | pollutant-temperature | 1 |
| 777 | polymer-nanorod | 5 |
| 778 | polymorphism-drug | 1 |
| 779 | porphyrin-substrate | 1 |
| 780 | post-assault | 2 |
| 781 | post-cement | 1 |
| 782 | pp2a-ppmt-1 | 1 |
| 783 | ppi-clopidogrel | 2 |
| 784 | precipitating | 199 |
| 785 | predictor×group | 1 |
| 786 | predisposing | 810 |
| 787 | preinstruction | 2 |
| 788 | preload-exercise | 1 |
| 789 | prerandomisation | 11 |
| 790 | previous-trial | 1 |
| 791 | previously-unknown | 2 |
| 792 | product-subject | 1 |
| 793 | product/surface | 1 |
| 794 | product/time | 1 |
| 795 | program-by-client | 2 |
| 796 | proline/g-quartet | 1 |
| 797 | prosody-syntax | 1 |
| 798 | protein-additive | 1 |
| 799 | protein-flavor | 1 |
| 800 | protein-glycan | 3 |
| 801 | protein-ligand | 39 |
| 802 | protein-membrane | 1 |
| 803 | protein-metabolite | 1 |
| 804 | protein-oligonucleotide | 2 |
| 805 | protein-polyanion | 1 |
| 806 | protein-polyphenol | 2 |
| 807 | protein-protein | 179 |
| 808 | protein-protein/dna | 1 |
| 809 | protein-rna | 3 |
| 810 | protein-saccharide | 1 |
| 811 | protein-solvent | 2 |
| 812 | protein/protein | 5 |
| 813 | protein–protein | 1 |
| 814 | proteome-diet | 1 |
| 815 | protist-bacterial | 1 |
| 816 | provider-by-group-by-time | 1 |
| 817 | provider-physician | 1 |
| 818 | pseudo-jahn-teller | 1 |
| 819 | psp94-crisp-3 | 2 |
| 820 | psychosocial/spiritual | 1 |
| 821 | pt/vacancy | 1 |
| 822 | pulmonary-cardiac | 1 |
| 823 | py-zeolite | 1 |
| 824 | qtl-by-environment | 1 |
| 825 | quasi-phase-matching | 1 |
| 826 | quercetin-drug | 1 |
| 827 | race-by-amlodipine/lisinopril | 1 |
| 828 | race-by-lisinopril/chlorthalidone | 1 |
| 829 | race-drug | 1 |
| 830 | race-fai | 1 |
| 831 | race-treatment | 2 |
| 832 | radiation-drug | 1 |
| 833 | ram-by-extender | 1 |
| 834 | randomization-by-time | 2 |
| 835 | rankl-rank | 3 |
| 836 | rbp4-ttr | 1 |
| 837 | receptor-ligand | 15 |
| 838 | receptor-sulfate | 1 |
| 839 | regulator-promoter | 1 |
| 840 | reported.subgroup | 1 |
| 841 | researcher-provider | 1 |
| 842 | resilience-abuse | 1 |
| 843 | response-prediction | 1 |
| 844 | rest-task | 2 |
| 845 | resveratrol-drug | 1 |
| 846 | retention-interval | 1 |
| 847 | reward-cognition | 1 |
| 848 | ribotoxin-lipid | 1 |
| 849 | risk/protective | 9 |
| 850 | rna-ago2 | 1 |
| 851 | rna-rna | 8 |
| 852 | roter | 13 |
| 853 | routinise | 1 |
| 854 | rs738409-sex | 2 |
| 855 | rtms-laterality | 1 |
| 856 | rtpa-by-variable | 1 |
| 857 | rubber-filler | 1 |
| 858 | rubber-rubber | 1 |
| 859 | rwa-wheat | 1 |
| 860 | rydberg-valence | 2 |
| 861 | s-h·π | 1 |
| 862 | safety-influencing | 1 |
| 863 | sah-related | 1 |
| 864 | sbd-substrate | 1 |
| 865 | sdf-1α-cxcr4 | 1 |
| 866 | seca/membrane | 1 |
| 867 | second-neighbor | 2 |
| 868 | sept-ap | 1 |
| 869 | ser19-phosphorylation-dependent | 1 |
| 870 | serotonin-glutamate | 1 |
| 871 | session*time | 2 |
| 872 | session-time | 1 |
| 873 | severity-of-illness | 3 |
| 874 | sex-age-treatment | 1 |
| 875 | sex-by-correlate | 1 |
| 876 | sex-by-drug | 1 |
| 877 | sex-by-supplement | 1 |
| 878 | sex-by-time | 2 |
| 879 | sex-by-treatment | 4 |
| 880 | sex-by-tstv | 1 |
| 881 | sex-diabetes | 2 |
| 882 | sex-partner | 1 |
| 883 | sexual-partner-related | 2 |
| 884 | sex×time | 1 |
| 885 | sex×treatment | 1 |
| 886 | se···o | 1 |
| 887 | se···o/n | 1 |
| 888 | sgf14-gmmyb176 | 1 |
| 889 | shcbt-by-time | 1 |
| 890 | shoot-root | 1 |
| 891 | side-chain-main-chain | 1 |
| 892 | simvastatin-diltiazem | 1 |
| 893 | site-by-treatment-by-time | 1 |
| 894 | site-site | 1 |
| 895 | sleep-disturbing | 2 |
| 896 | sleep-pain | 1 |
| 897 | smoking-selenium | 1 |
| 898 | snp-by-sex | 1 |
| 899 | snp-by-time | 1 |
| 900 | snp-diet | 4 |
| 901 | snp-education | 3 |
| 902 | snp-snp | 2 |
| 903 | society-forest | 1 |
| 904 | solvent-1,2,3-trz | 1 |
| 905 | soybean-pathogen | 1 |
| 906 | sp-a/crp | 2 |
| 907 | species-pathogen | 1 |
| 908 | sperm/mucus | 2 |
| 909 | spin–orbit | 1 |
| 910 | stacking | 238 |
| 911 | staff-caregiver | 3 |
| 912 | staff-consumer | 1 |
| 913 | staff-resident | 1 |
| 914 | staff-to-staff | 1 |
| 915 | stas-stas | 1 |
| 916 | std-hiv | 1 |
| 917 | stent-type-by-treatment | 1 |
| 918 | stent-vessel | 2 |
| 919 | steroid-inflammasome | 1 |
| 920 | strain-by-drug | 1 |
| 921 | strain×diet | 1 |
| 922 | stress-alcohol | 1 |
| 923 | stress-hemoconcentration | 2 |
| 924 | study-by-treatment | 3 |
| 925 | subgroup-by-therapy | 1 |
| 926 | subgroup-by-treatment | 3 |
| 927 | subgroup-treatment | 1 |
| 928 | subgroup×time | 1 |
| 929 | subject-by-formulation | 3 |
| 930 | subject-treatment | 3 |
| 931 | substrate-enzyme | 2 |
| 932 | substrate-lipase | 1 |
| 933 | superexchange | 8 |
| 934 | supervisor-trainee | 1 |
| 935 | supplement-drug | 3 |
| 936 | supplement-supplement | 1 |
| 937 | supplement/time | 1 |
| 938 | support-metal | 1 |
| 939 | surgery-by-treatment | 1 |
| 940 | sweetener-drug | 1 |
| 941 | synaptopodin/14-3-3β | 1 |
| 942 | synergistic/antagonistic/suppressing | 1 |
| 943 | syntax-prosody | 1 |
| 944 | synthetic-genetic | 1 |
| 945 | system-reservoir | 2 |
| 946 | s···n/s | 1 |
| 947 | s···o | 2 |
| 948 | tactile-pain | 1 |
| 949 | tak1/tab2 | 1 |
| 950 | tamoxifen/norfloxacin | 1 |
| 951 | task-rule | 3 |
| 952 | tau-tau | 2 |
| 953 | tds×medication | 1 |
| 954 | tec-thymocyte | 1 |
| 955 | te⋯o | 1 |
| 956 | tf's-target | 1 |
| 957 | tf-dna | 1 |
| 958 | tfap2b-macronutrient | 1 |
| 959 | tg2-fn | 2 |
| 960 | th-cell | 1 |
| 961 | th-partner | 1 |
| 962 | thc-ache | 1 |
| 963 | therapist-subject | 1 |
| 964 | therapy-by-age | 1 |
| 965 | therapy-by-time | 1 |
| 966 | thiol-mediated | 1 |
| 967 | through-bond | 2 |
| 968 | through-space | 3 |
| 969 | thujopsene-drug | 1 |
| 970 | thyroid-catecholamine | 1 |
| 971 | tick-rickettsia | 1 |
| 972 | time*group | 6 |
| 973 | time-by-condition | 4 |
| 974 | time-by-group | 31 |
| 975 | time-by-regimen | 2 |
| 976 | time-by-stratum | 1 |
| 977 | time-by-treatment | 18 |
| 978 | time-covariate | 1 |
| 979 | time-dca | 1 |
| 980 | time-gender | 1 |
| 981 | time-group | 11 |
| 982 | time-of-entry | 1 |
| 983 | time-survival | 1 |
| 984 | time-treatment | 5 |
| 985 | time×group | 8 |
| 986 | time×meal | 1 |
| 987 | time×treatment | 9 |
| 988 | time×trial | 1 |
| 989 | tl1a-dr3 | 1 |
| 990 | tlr-4-rwmhsp60 | 1 |
| 991 | tms-2 | 2 |
| 992 | tnf-alpha-tnf-receptor | 1 |
| 993 | tnf-il-1 | 1 |
| 994 | tomato-oil | 1 |
| 995 | tooth-composite | 2 |
| 996 | top/cm | 1 |
| 997 | toxin-channel | 1 |
| 998 | tradic | 1 |
| 999 | trainee-supervisor | 1 |
| 1000 | trainer-trainee | 2 |
| 1001 | trait-task | 1 |
| 1002 | trait×situation | 2 |
| 1003 | translation-independent | 2 |
| 1004 | trauma-by-treatment-by-time | 1 |
| 1005 | treatment-baseline | 1 |
| 1006 | treatment-biomarker | 5 |
| 1007 | treatment-by-age | 6 |
| 1008 | treatment-by-age-group | 2 |
| 1009 | treatment-by-anxiety | 1 |
| 1010 | treatment-by-baseline | 2 |
| 1011 | treatment-by-biomarker | 3 |
| 1012 | treatment-by-bmi | 2 |
| 1013 | treatment-by-center | 3 |
| 1014 | treatment-by-centre | 4 |
| 1015 | treatment-by-clinic | 1 |
| 1016 | treatment-by-country | 2 |
| 1017 | treatment-by-covariate | 7 |
| 1018 | treatment-by-diagnosis | 1 |
| 1019 | treatment-by-ed-status | 1 |
| 1020 | treatment-by-factor | 2 |
| 1021 | treatment-by-gender | 4 |
| 1022 | treatment-by-genotype | 3 |
| 1023 | treatment-by-gfr | 2 |
| 1024 | treatment-by-histology | 4 |
| 1025 | treatment-by-investigator | 1 |
| 1026 | treatment-by-lesion-size | 1 |
| 1027 | treatment-by-period | 1 |
| 1028 | treatment-by-race | 2 |
| 1029 | treatment-by-region | 2 |
| 1030 | treatment-by-sex | 3 |
| 1031 | treatment-by-strata | 2 |
| 1032 | treatment-by-strata-by-time | 1 |
| 1033 | treatment-by-stratum | 1 |
| 1034 | treatment-by-study | 2 |
| 1035 | treatment-by-subgroup | 14 |
| 1036 | treatment-by-subset | 2 |
| 1037 | treatment-by-time | 29 |
| 1038 | treatment-by-visit | 1 |
| 1039 | treatment-by-volume | 2 |
| 1040 | treatment-by-weight | 1 |
| 1041 | treatment-covariate | 9 |
| 1042 | treatment-gender | 2 |
| 1043 | treatment-gene | 1 |
| 1044 | treatment-genotype | 1 |
| 1045 | treatment-marker | 1 |
| 1046 | treatment-polymorphism | 1 |
| 1047 | treatment-subgroup | 10 |
| 1048 | treatment-time | 24 |
| 1049 | treatment-to-time | 1 |
| 1050 | treatment-visit | 2 |
| 1051 | treatment×cs | 1 |
| 1052 | treatment×time | 9 |
| 1053 | trial-by-time | 2 |
| 1054 | troponin-c | 2 |
| 1055 | trp-lipid | 1 |
| 1056 | trp159-asp126 | 1 |
| 1057 | tslp-tslpr | 1 |
| 1058 | tumor-stroma | 4 |
| 1059 | tumor-vascular | 1 |
| 1060 | tumor/bone | 1 |
| 1061 | u-c | 1 |
| 1062 | u2af-rna | 1 |
| 1063 | udca-haplotype | 1 |
| 1064 | unit-treatment | 4 |
| 1065 | unmeasured | 172 |
| 1066 | unmeasured/unobserved | 1 |
| 1067 | unmodifiable | 13 |
| 1068 | upf1-rna | 1 |
| 1069 | ura2-hsp90 | 1 |
| 1070 | user-device | 1 |
| 1071 | v-rr | 2 |
| 1072 | varenicline-drug | 1 |
| 1073 | variable-by-treatment | 1 |
| 1074 | vas-genotype | 1 |
| 1075 | vector-parasite | 2 |
| 1076 | vector-pathogen | 3 |
| 1077 | ventricular-valve | 1 |
| 1078 | ventricular-ventricular | 8 |
| 1079 | vertebra-specific | 4 |
| 1080 | vildagliptin-dpp-4 | 1 |
| 1081 | viral-host | 1 |
| 1082 | virtual-human | 2 |
| 1083 | virus-bacterial-host | 1 |
| 1084 | virus-host | 17 |
| 1085 | virus/host | 2 |
| 1086 | visit-by-treatment | 1 |
| 1087 | visual-nociceptive | 1 |
| 1088 | vwf-galectin | 1 |
| 1089 | warfarin-fluconazole | 1 |
| 1090 | warfarin-levofloxacin | 1 |
| 1091 | water-fa | 1 |
| 1092 | water-hydrocarbon | 1 |
| 1093 | water-rock | 1 |
| 1094 | wm-attention | 1 |
| 1095 | ximelagatran-erythromycin | 1 |
| 1096 | xylan-cellulose | 1 |
| 1097 | yl.chn1p/ssa1p | 1 |
| 1098 | zno×phytase | 2 |
| 1099 | zns-pmma | 1 |
| 1100 | zooplankton-cyanobacteria | 1 |
| 1101 | β2/14-3-3-ζ | 1 |
| 1102 | δglucose×gender | 1 |
| 1103 | π-cation | 5 |
| 1104 | π-ring⋯carbon-yl | 1 |
| 1105 | π-stacking | 18 |
| 1106 | π-π | 268 |
| 1107 | π-π-stacking | 3 |
| 1108 | π···π | 13 |
| 1109 | π–π | 5 |
| 1 | tlr-4-rwmhsp60 | 1 |
| 2 | cx43-hsc70 | 1 |
| 3 | aba-hsp70 | 2 |
| 4 | cp-hsp70 | 1 |
| 5 | ura2-hsp90 | 1 |
| 6 | cpr6-hsp90 | 1 |
| 7 | /hsp90 | 1 |
| 8 | cb2/hsp90 | 1 |
| 9 | ctx-upa/pai-1 | 1 |
| 10 | tnf-il-1 | 1 |
| 11 | pp2a-ppmt-1 | 1 |
| 12 | drug/t1301 | 1 |
| 13 | lmir5-c24:1 | 1 |
| 14 | 14-3-3ζ/gabab1 | 1 |
| 15 | 14-3-3ɛ-vdac1 | 1 |
| 16 | myh/ape1 | 1 |
| 17 | hsp90-gch1 | 3 |
| 18 | hsp90/gch1 | 1 |
| 19 | dll4-notch1 | 1 |
| 20 | bcl2-becn1 | 1 |
| 21 | gh14-3-3-ghbzr1 | 1 |
| 22 | dbc1-sirt1 | 2 |
| 23 | cb1/trpv1 | 1 |
| 24 | tms-2 | 2 |
| 25 | tak1/tab2 | 1 |
| 26 | lfa-3/cd2 | 1 |
| 27 | hsp90-inrf2 | 3 |
| 28 | o-h···nh2 | 1 |
| 29 | lnk-jak2 | 1 |
| 30 | p53/mdm2 | 2 |
| 31 | rna-ago2 | 1 |
| 32 | kif23-14-3-3 | 1 |
| 33 | erα/14-3-3 | 3 |
| 34 | lef-3-lef-3 | 1 |
| 35 | gal-3/gal-3 | 1 |
| 36 | integrin-kindlin-3 | 3 |
| 37 | nox4/mkp-3 | 1 |
| 38 | psp94-crisp-3 | 2 |
| 39 | adipor1/cav-3 | 2 |
| 40 | dicer1-p-smad2/3 | 1 |
| 41 | actin-arp2/3 | 1 |
| 42 | /p23 | 2 |
| 43 | hsp90β/p23 | 1 |
| 44 | mdm2-p53 | 3 |
| 45 | mdm2/p53 | 7 |
| 46 | met-hsp83 | 1 |
| 47 | paip1-eif3 | 3 |
| 48 | ddx3-irf3 | 1 |
| 49 | o5'-h···n3 | 1 |
| 50 | in-tnpo3 | 1 |
| 51 | gpr30-ramp3 | 1 |
| 52 | tl1a-dr3 | 1 |
| 53 | her2/her3 | 1 |
| 54 | hsp27/tlr3 | 1 |
| 55 | ebs3-ibs3 | 1 |
| 56 | artn-gfrα3 | 1 |
| 57 | vildagliptin-dpp-4 | 1 |
| 58 | cd40/cd154 | 1 |
| 59 | gp120-cd4 | 1 |
| 60 | hbd-3-cxcr4 | 1 |
| 61 | sdf-1α-cxcr4 | 1 |
| 62 | atg14l-vps34/vps15 | 2 |
| 63 | pa-pb1-ipo5 | 1 |
| 64 | trp159-asp126 | 1 |
| 65 | sgf14-gmmyb176 | 1 |
| 66 | hsp90/cdc37 | 1 |
| 67 | cd28/b7 | 1 |
| 68 | cpc7 | 2 |
| 69 | h3.3k36me3/bs69 | 1 |
| 70 | cpsf-aauaaa | 1 |
| 71 | md-2/zaa | 1 |
| 72 | coral-cca | 1 |
| 73 | time-dca | 1 |
| 74 | air-sea | 4 |
| 75 | water-fa | 1 |
| 76 | gpr43-scfa | 1 |
| 77 | phytoplankton-bacteria | 1 |
| 78 | host-bacteria | 3 |
| 79 | microalgae/bacteria | 1 |
| 80 | zooplankton-cyanobacteria | 1 |
| 81 | tick-rickettsia | 1 |
| 82 | ofc-amygdala | 1 |
| 83 | zns-pmma | 1 |
| 84 | tumor-stroma | 4 |
| 85 | plant-phytoplasma | 1 |
| 86 | tf-dna | 1 |
| 87 | hnrnpk-dna | 1 |
| 88 | ll-37/dna | 1 |
| 89 | protein-protein/dna | 1 |
| 90 | cpsf30-rna | 1 |
| 91 | upf1-rna | 1 |
| 92 | rna-rna | 8 |
| 93 | u2af-rna | 1 |
| 94 | protein-rna | 3 |
| 95 | mirna-mrna | 3 |
| 96 | mirna/mrna | 2 |
| 97 | mrna-microrna | 1 |
| 98 | /rhoa | 1 |
| 99 | endothelin-ra | 1 |
| 100 | host-microflora | 1 |
| 101 | egcg-bsa | 1 |
| 102 | 5-hmf-hsa/bsa | 1 |
| 103 | treatment-by-strata | 2 |
| 104 | diet-microbiota | 1 |
| 105 | dzyaloshinskii-moriya | 1 |
| 106 | c6-b | 1 |
| 107 | p311-eif3b | 2 |
| 108 | fab-fab | 1 |
| 109 | bacterial/hab | 1 |
| 110 | nutrient/hab | 1 |
| 111 | food-web | 1 |
| 112 | p-thpp-hb | 1 |
| 113 | intra-herb | 1 |
| 114 | herb-herb | 14 |
| 115 | drug-herb/herb-herb | 1 |
| 116 | corticosteroid-herb | 1 |
| 117 | drug-herb | 33 |
| 118 | etra/etrb | 1 |
| 119 | al-c | 1 |
| 120 | troponin-c | 2 |
| 121 | u-c | 1 |
| 122 | pulmonary-cardiac | 1 |
| 123 | cardiac/noncardiac | 1 |
| 124 | galectin-3/polylacnac | 1 |
| 125 | tradic | 1 |
| 126 | vertebra-specific | 4 |
| 127 | fpr-specific | 1 |
| 128 | item-unspecific | 1 |
| 129 | encephalographic | 3 |
| 130 | cuprophilic | 3 |
| 131 | aurophilic | 11 |
| 132 | argentophilic | 1 |
| 133 | aetiopathogenic | 2 |
| 134 | amblyogenic | 8 |
| 135 | treatment-by-clinic | 1 |
| 136 | dromotropic | 2 |
| 137 | neurotopic | 1 |
| 138 | dnaa-oric | 1 |
| 139 | initiator-oric | 1 |
| 140 | medical/obstetric | 5 |
| 141 | aromatic-aromatic | 1 |
| 142 | epistatic | 27 |
| 143 | magnetostatic | 1 |
| 144 | synthetic-genetic | 1 |
| 145 | aetiopathogenetic | 5 |
| 146 | antiferro-magnetic | 3 |
| 147 | pharmacodynamic-kinetic | 1 |
| 148 | group-by-soc | 1 |
| 149 | hb101-uc | 1 |
| 150 | bacteria-uc | 1 |
| 151 | cl⋅⋅⋅c | 1 |
| 152 | hsp20-pde4d | 1 |
| 153 | mg-cd | 1 |
| 154 | environment-speed | 2 |
| 155 | group-by-speed | 1 |
| 156 | gsk-3-shared | 1 |
| 157 | unmeasured | 172 |
| 158 | metabolic-based | 2 |
| 159 | gesture-based | 1 |
| 160 | framingham-based | 4 |
| 161 | assessment-based | 8 |
| 162 | angio-associated | 1 |
| 163 | peptide-mediated | 2 |
| 164 | cell-cell-mediated | 1 |
| 165 | thiol-mediated | 1 |
| 166 | myopia-related | 1 |
| 167 | bmd-related | 1 |
| 168 | loading-related | 2 |
| 169 | sah-related | 1 |
| 170 | lipoprotein-related | 10 |
| 171 | occlusion-related | 1 |
| 172 | sexual-partner-related | 2 |
| 173 | caries-related | 5 |
| 174 | carbon-substituted | 1 |
| 175 | casa-derived | 1 |
| 176 | unmeasured/unobserved | 1 |
| 177 | catalase-amyloid | 4 |
| 178 | agmatine-cannabinoid | 1 |
| 179 | drug-flavonoid | 1 |
| 180 | gene-by-flavonoid | 1 |
| 181 | drug-steroid | 1 |
| 182 | host-parasitoid | 3 |
| 183 | lipid-lipid | 1 |
| 184 | ribotoxin-lipid | 1 |
| 185 | trp-lipid | 1 |
| 186 | animal-fluid | 1 |
| 187 | ccr4-ligand | 1 |
| 188 | dna-ligand | 1 |
| 189 | ligand-ligand | 4 |
| 190 | heme-ligand | 2 |
| 191 | enzyme-ligand | 4 |
| 192 | ag-ligand | 1 |
| 193 | protein-ligand | 39 |
| 194 | receptor-ligand | 15 |
| 195 | through-bond | 2 |
| 196 | center-surround | 1 |
| 197 | groups*period | 1 |
| 198 | treatment-by-period | 1 |
| 199 | drug-food | 19 |
| 200 | oil-food | 1 |
| 201 | drug–food | 1 |
| 202 | head-rod | 1 |
| 203 | polymer-nanorod | 5 |
| 204 | depression-by-ptsd | 1 |
| 205 | human-microbe | 2 |
| 206 | plant-microbe | 3 |
| 207 | host-microbe | 15 |
| 208 | edge-to-face | 5 |
| 209 | blood-surface | 1 |
| 210 | co-surface | 1 |
| 211 | gas-surface | 4 |
| 212 | cell/surface | 1 |
| 213 | gas/surface | 2 |
| 214 | product/surface | 1 |
| 215 | through-space | 3 |
| 216 | gender-by-race | 1 |
| 217 | treatment-by-race | 2 |
| 218 | corticosteroid-licorice | 1 |
| 219 | device-device | 1 |
| 220 | user-device | 1 |
| 221 | rydberg-valence | 2 |
| 222 | additivity/indifference | 1 |
| 223 | condition×sequence | 1 |
| 224 | group×time×grade | 2 |
| 225 | gfj-loperamide | 1 |
| 226 | gemfibrozil-repaglinide | 1 |
| 227 | protein-saccharide | 1 |
| 228 | protein-oligonucleotide | 2 |
| 229 | interpeptide | 2 |
| 230 | trainer-trainee | 2 |
| 231 | supervisor-trainee | 1 |
| 232 | occasion-amputee | 1 |
| 233 | intervention*age | 1 |
| 234 | drug-by-age | 1 |
| 235 | intervention-by-age | 1 |
| 236 | group-by-age | 1 |
| 237 | treatment-by-age | 6 |
| 238 | therapy-by-age | 1 |
| 239 | ipaf-macrophage | 1 |
| 240 | glap-rage | 1 |
| 241 | group-by-stage | 1 |
| 242 | between-language | 1 |
| 243 | superexchange | 8 |
| 244 | thc-ache | 1 |
| 245 | hydrogen-bond-like | 3 |
| 246 | affinity-like | 1 |
| 247 | influenceable | 2 |
| 248 | modifiable | 879 |
| 249 | non-modifiable | 20 |
| 250 | nonmodifiable | 25 |
| 251 | unmodifiable | 13 |
| 252 | rtpa-by-variable | 1 |
| 253 | covariable | 14 |
| 254 | eliminable | 1 |
| 255 | alterable | 5 |
| 256 | bubble-bubble | 1 |
| 257 | dipole-dipole | 22 |
| 258 | dipole-quadrupole | 9 |
| 259 | warfarin-fluconazole | 1 |
| 260 | dipole-quadruple | 1 |
| 261 | ligand-macromolecule | 1 |
| 262 | molecule-biomacromolecule | 1 |
| 263 | task-rule | 3 |
| 264 | gene-lifestyle | 2 |
| 265 | session*time | 2 |
| 266 | genotype-time | 1 |
| 267 | session-time | 1 |
| 268 | condition-time | 1 |
| 269 | treatment-to-time | 1 |
| 270 | group-time | 12 |
| 271 | diet-time | 1 |
| 272 | treatment-time | 24 |
| 273 | group-x-time | 2 |
| 274 | -by-time | 1 |
| 275 | treatment-by-strata-by-time | 1 |
| 276 | genotype-by-time | 1 |
| 277 | dose-by-time | 1 |
| 278 | drug-by-time | 3 |
| 279 | trial-by-time | 2 |
| 280 | medication-by-time | 1 |
| 281 | randomization-by-time | 2 |
| 282 | condition-by-time | 10 |
| 283 | snp-by-time | 1 |
| 284 | group-by-time | 151 |
| 285 | provider-by-group-by-time | 1 |
| 286 | shcbt-by-time | 1 |
| 287 | treatment-by-time | 29 |
| 288 | trauma-by-treatment-by-time | 1 |
| 289 | site-by-treatment-by-time | 1 |
| 290 | sex-by-time | 2 |
| 291 | therapy-by-time | 1 |
| 292 | modality-time | 1 |
| 293 | condition/time | 1 |
| 294 | product/time | 1 |
| 295 | supplement/time | 1 |
| 296 | group×load×time | 1 |
| 297 | drug×time | 1 |
| 298 | condition×time | 2 |
| 299 | group×time | 45 |
| 300 | subgroup×time | 1 |
| 301 | diagnosis×time | 2 |
| 302 | treatment×time | 9 |
| 303 | sex×time | 1 |
| 304 | steroid-inflammasome | 1 |
| 305 | excluded-volume | 2 |
| 306 | treatment-by-volume | 2 |
| 307 | -enzyme | 1 |
| 308 | substrate-enzyme | 2 |
| 309 | drug-enzyme | 1 |
| 310 | metal-methane | 1 |
| 311 | lo18-membrane | 1 |
| 312 | blood-membrane | 1 |
| 313 | drug-membrane | 2 |
| 314 | protein-membrane | 1 |
| 315 | /membrane | 1 |
| 316 | seca/membrane | 1 |
| 317 | gene-gene | 44 |
| 318 | homocysteine-gene | 1 |
| 319 | drug-gene | 1 |
| 320 | gender-gene | 1 |
| 321 | diet-gene | 5 |
| 322 | nutrient-gene | 3 |
| 323 | treatment-gene | 1 |
| 324 | gene×gene | 1 |
| 325 | arginine-arene | 2 |
| 326 | arene-perfluoroarene | 2 |
| 327 | methyl-ene-bromo-benzene | 1 |
| 328 | gfj-fexofenadine | 1 |
| 329 | csa-isoprenaline | 1 |
| 330 | treatment-baseline | 1 |
| 331 | treatment-by-baseline | 2 |
| 332 | age-rasagiline | 1 |
| 333 | thyroid-catecholamine | 1 |
| 334 | brain-catecholamine | 1 |
| 335 | perindoprilmethamphetamine | 1 |
| 336 | gender-by-lisinopril/amlodipine | 1 |
| 337 | endocrine-immune-paracrine | 1 |
| 338 | intetumumab-dacarbazine | 1 |
| 339 | tumor/bone | 1 |
| 340 | race-by-lisinopril/chlorthalidone | 1 |
| 341 | microbiota-hormone | 1 |
| 342 | cta1-chaperone | 1 |
| 343 | bacteria-immune | 1 |
| 344 | commensal-immune | 1 |
| 345 | placebo-type | 1 |
| 346 | udca-haplotype | 1 |
| 347 | genotype-genotype | 1 |
| 348 | vas-genotype | 1 |
| 349 | diet-genotype | 1 |
| 350 | treatment-genotype | 1 |
| 351 | treatment-by-genotype | 3 |
| 352 | 32-core | 1 |
| 353 | ligand-core | 1 |
| 354 | treatment-by-centre | 4 |
| 355 | confounder-exposure | 1 |
| 356 | platelet-microvasculature | 1 |
| 357 | o3-temperature | 1 |
| 358 | oxygen-temperature | 2 |
| 359 | pollutant-temperature | 1 |
| 360 | fluid-structure | 6 |
| 361 | agency-structure | 1 |
| 362 | nature-nurture | 3 |
| 363 | diabetic-disease | 1 |
| 364 | drug-disease | 34 |
| 365 | nutrient-disease | 2 |
| 366 | drug/disease | 1 |
| 367 | substrate-lipase | 1 |
| 368 | zno×phytase | 2 |
| 369 | hsf1/dhse | 1 |
| 370 | preload-exercise | 1 |
| 371 | nutrient-exercise | 1 |
| 372 | obesity-by-exercise | 1 |
| 373 | metformin×exercise | 1 |
| 374 | routinise | 1 |
| 375 | gonadotrophin-dose | 1 |
| 376 | food-by-dose | 1 |
| 377 | gene-by-dose | 2 |
| 378 | xylan-cellulose | 1 |
| 379 | resilience-abuse | 1 |
| 380 | adsorbate-adsorbate | 1 |
| 381 | receptor-sulfate | 1 |
| 382 | base-phosphate | 1 |
| 383 | co-variate | 5 |
| 384 | covariate | 1,011 |
| 385 | time-covariate | 1 |
| 386 | effect-covariate | 1 |
| 387 | treatment-covariate | 9 |
| 388 | treatment-by-covariate | 7 |
| 389 | sex-by-correlate | 1 |
| 390 | serotonin-glutamate | 1 |
| 391 | fat-carbohydrate | 1 |
| 392 | sbd-substrate | 1 |
| 393 | molecule-substrate | 2 |
| 394 | porphyrin-substrate | 1 |
| 395 | dimer-substrate | 1 |
| 396 | epithelium-gamete | 1 |
| 397 | drug-metabolite | 1 |
| 398 | protein-metabolite | 1 |
| 399 | co2-zeolite | 1 |
| 400 | py-zeolite | 1 |
| 401 | site-site | 1 |
| 402 | vector-parasite | 2 |
| 403 | host∶parasite | 1 |
| 404 | tooth-composite | 2 |
| 405 | fronte | 2 |
| 406 | tec-thymocyte | 1 |
| 407 | endocardial-endothelial/cardiomyocyte | 1 |
| 408 | gender-cue | 1 |
| 409 | plasma-tissue | 2 |
| 410 | blood-tissue | 4 |
| 411 | particle-tissue | 1 |
| 412 | laser-tissue | 5 |
| 413 | light-tissue | 2 |
| 414 | epinephrine/hypertensive | 1 |
| 415 | hyperconjucative | 1 |
| 416 | coaggregative | 1 |
| 417 | hyper-conjugative | 22 |
| 418 | hyperconjugative | 15 |
| 419 | risk/protective | 9 |
| 420 | more-than-additive | 1 |
| 421 | protein-additive | 1 |
| 422 | visual-nociceptive | 1 |
| 423 | blood-valve | 1 |
| 424 | ventricular-valve | 1 |
| 425 | peptide-in-groove | 1 |
| 426 | treatment-by-lesion-size | 1 |
| 427 | g×e | 1 |
| 428 | hn-f | 1 |
| 429 | staff-to-staff | 1 |
| 430 | overriding/trade-off | 1 |
| 431 | mother-calf | 1 |
| 432 | coral-turf | 1 |
| 433 | ag⋯f | 3 |
| 434 | n-h⋯f | 5 |
| 435 | cpox4-hg | 1 |
| 436 | sleep-disturbing | 2 |
| 437 | safety-influencing | 1 |
| 438 | h-bonding | 28 |
| 439 | hydrogen-bonding | 85 |
| 440 | non-bonding | 2 |
| 441 | nonbonding | 6 |
| 442 | onfounding | 1 |
| 443 | confounding | 2,243 |
| 444 | quasi-phase-matching | 1 |
| 445 | overtaking | 2 |
| 446 | stacking | 238 |
| 447 | π-stacking | 18 |
| 448 | π-π-stacking | 3 |
| 449 | age-smoking | 1 |
| 450 | gene-smoking | 1 |
| 451 | gene-by-smoking | 2 |
| 452 | pi*z-by-smoking | 1 |
| 453 | coupling/decoupling | 1 |
| 454 | age-by-gender-by-framing | 1 |
| 455 | ih901-training | 1 |
| 456 | cluster-defining | 1 |
| 457 | aromatic-ring | 1 |
| 458 | maternal/offspring | 1 |
| 459 | category-comprising | 1 |
| 460 | predisposing | 810 |
| 461 | synergistic/antagonistic/suppressing | 1 |
| 462 | heat-exacerbating | 1 |
| 463 | metal-coordinating | 2 |
| 464 | precipitating | 199 |
| 465 | aggravating | 113 |
| 466 | cost-driving | 1 |
| 467 | effect-modifying | 9 |
| 468 | dopamine/dmpg | 1 |
| 469 | ccna2-drug | 1 |
| 470 | dna-drug | 1 |
| 471 | herb-drug | 96 |
| 472 | antibiotic-drug | 1 |
| 473 | food-drug | 12 |
| 474 | race-drug | 1 |
| 475 | device-drug | 1 |
| 476 | age-drug | 1 |
| 477 | enzyme-drug | 1 |
| 478 | gene-drug | 7 |
| 479 | thujopsene-drug | 1 |
| 480 | varenicline-drug | 1 |
| 481 | haplotype-drug | 1 |
| 482 | hg-drug | 1 |
| 483 | drug-drug | 510 |
| 484 | ki-drug | 1 |
| 485 | gfj-drug | 1 |
| 486 | herbal-drug | 7 |
| 487 | botanical-drug | 1 |
| 488 | clopidogrel-drug | 1 |
| 489 | resveratrol-drug | 1 |
| 490 | polymorphism-drug | 1 |
| 491 | quercetin-drug | 1 |
| 492 | radiation-drug | 1 |
| 493 | drug-to-drug | 7 |
| 494 | chp-drug | 1 |
| 495 | crp-drug | 1 |
| 496 | gender-drug | 1 |
| 497 | sweetener-drug | 1 |
| 498 | ds-drug | 1 |
| 499 | diet-drug | 4 |
| 500 | nutrient-drug | 4 |
| 501 | supplement-drug | 3 |
| 502 | strain-by-drug | 1 |
| 503 | sex-by-drug | 1 |
| 504 | liquorice-herb/drug | 1 |
| 505 | icd/drug | 1 |
| 506 | genotype/drug | 1 |
| 507 | medications/drug | 1 |
| 508 | herbdrug | 1 |
| 509 | drug–drug | 1 |
| 510 | fröhlich | 1 |
| 511 | both-through | 1 |
| 512 | race-fai | 1 |
| 513 | treatment-by-bmi | 2 |
| 514 | pi-pi | 4 |
| 515 | cation-pi | 1 |
| 516 | clopidogrel-ppi | 1 |
| 517 | c-h···ti | 1 |
| 518 | capase-3/calbindin-d28k | 1 |
| 519 | water-rock | 1 |
| 520 | drug-milk | 1 |
| 521 | rankl-rank | 3 |
| 522 | trait-task | 1 |
| 523 | rest-task | 2 |
| 524 | group-by-task | 1 |
| 525 | cell/phbhhx-l | 1 |
| 526 | ox40/ox40l | 1 |
| 527 | al-au-al/b-au-al | 2 |
| 528 | drug-vitamin-herbal | 1 |
| 529 | inter-herbal | 1 |
| 530 | epistatic-environmental-biological | 1 |
| 531 | chemo-biological | 1 |
| 532 | clinicoroentgenological | 1 |
| 533 | nonreciprocal | 3 |
| 534 | time×meal | 1 |
| 535 | plant-fungal | 1 |
| 536 | microbial-microbial | 1 |
| 537 | host-microbial | 5 |
| 538 | interracial | 7 |
| 539 | parasocial | 3 |
| 540 | inter-collegial | 1 |
| 541 | leukocyte-epithelial | 1 |
| 542 | caf-epithelial | 1 |
| 543 | pmn-epithelial | 1 |
| 544 | leukoycte-endothelial | 1 |
| 545 | leukocyte-platelet-endothelial | 1 |
| 546 | neutrophil/endothelial | 2 |
| 547 | blood-material | 1 |
| 548 | epithelial-bacterial | 1 |
| 549 | protist-bacterial | 1 |
| 550 | 1,3-equatorial | 1 |
| 551 | previous-trial | 1 |
| 552 | time×trial | 1 |
| 553 | medication×stress×trial | 1 |
| 554 | 1,3-syn-axial | 1 |
| 555 | epithelial-stromal | 5 |
| 556 | inter-chromosomal | 1 |
| 557 | emerged-medicinal | 1 |
| 558 | client-professional | 1 |
| 559 | peritransplantational | 1 |
| 560 | gene-nutritional | 1 |
| 561 | microglial-neuronal | 1 |
| 562 | anti-malarial-anti-retroviral | 1 |
| 563 | disulfiram-chloral | 1 |
| 564 | human/environmental/cultural | 1 |
| 565 | laser-metal | 1 |
| 566 | support-metal | 1 |
| 567 | olfactory-visual | 2 |
| 568 | psychosocial/spiritual | 1 |
| 569 | inter-sexual | 2 |
| 570 | time-survival | 1 |
| 571 | retention-interval | 1 |
| 572 | h···cl | 1 |
| 573 | day×gel | 1 |
| 574 | pip2-channel | 1 |
| 575 | drug-channel | 1 |
| 576 | toxin-channel | 1 |
| 577 | ppi-clopidogrel | 2 |
| 578 | stent-vessel | 2 |
| 579 | guideline-level | 1 |
| 580 | organization-level | 2 |
| 581 | er-level | 1 |
| 582 | cross-level | 6 |
| 583 | tomato-oil | 1 |
| 584 | race-by-amlodipine/lisinopril | 1 |
| 585 | pollen-pistil | 3 |
| 586 | gas-wall | 2 |
| 587 | drug-cell | 2 |
| 588 | th-cell | 1 |
| 589 | apolipoprotein-cell | 1 |
| 590 | drug-alcohol | 3 |
| 591 | stress-alcohol | 1 |
| 592 | nonsmoking/propranolol | 1 |
| 593 | protein-polyphenol | 2 |
| 594 | cloud-aerosol | 1 |
| 595 | c-h⋯ocarbon-yl | 2 |
| 596 | π-ring⋯carbon-yl | 1 |
| 597 | carbonyl-carbonyl | 1 |
| 598 | acd-cam | 2 |
| 599 | drug-cam | 1 |
| 600 | top/cm | 1 |
| 601 | cell-ecm | 2 |
| 602 | simvastatin-diltiazem | 1 |
| 603 | group-by-time-by-arm | 1 |
| 604 | dose-form | 1 |
| 605 | treatment-polymorphism | 1 |
| 606 | drug-organism | 1 |
| 607 | host-organism | 2 |
| 608 | plant-microorganism | 1 |
| 609 | gender/lithium | 1 |
| 610 | leukocyte-endothelium | 3 |
| 611 | platelet-endothelium | 1 |
| 612 | arsenic/cadmium | 2 |
| 613 | smoking-selenium | 1 |
| 614 | copper-selenium | 1 |
| 615 | time-by-stratum | 1 |
| 616 | treatment-by-stratum | 1 |
| 617 | se···o/n | 1 |
| 618 | -glycan | 1 |
| 619 | ha-glycan | 2 |
| 620 | glycan-glycan | 1 |
| 621 | protein-glycan | 3 |
| 622 | lectin-glycan | 1 |
| 623 | coulombian | 1 |
| 624 | mode-physician | 1 |
| 625 | provider-physician | 1 |
| 626 | industry-physician | 1 |
| 627 | machine-human | 1 |
| 628 | virtual-human | 2 |
| 629 | birds/human | 1 |
| 630 | ch₃cn-ch₃cn | 1 |
| 631 | colah-collagen | 1 |
| 632 | pnictogen-chalcogen | 1 |
| 633 | soybean-pathogen | 1 |
| 634 | vector-pathogen | 3 |
| 635 | species-pathogen | 1 |
| 636 | insect-pathogen | 1 |
| 637 | plant-pathogen | 10 |
| 638 | host-pathogen | 38 |
| 639 | antibody-pathogen | 1 |
| 640 | host/pathogen | 1 |
| 641 | halogen-halogen | 2 |
| 642 | time-by-regimen | 2 |
| 643 | mother-children | 2 |
| 644 | tg2-fn | 2 |
| 645 | o-hn | 1 |
| 646 | ledgf/p75-in | 1 |
| 647 | side-chain-main-chain | 1 |
| 648 | tactile-pain | 1 |
| 649 | sleep-pain | 1 |
| 650 | caffeine-haemoglobin | 1 |
| 651 | drug-bilirubin | 1 |
| 652 | warfarin-levofloxacin | 1 |
| 653 | tamoxifen/norfloxacin | 1 |
| 654 | ximelagatran-erythromycin | 1 |
| 655 | nectin-afadin | 2 |
| 656 | phenolic-casein | 1 |
| 657 | dna-protein | 9 |
| 658 | mb-protein | 1 |
| 659 | nanoparticle-protein | 1 |
| 660 | molecule-protein | 4 |
| 661 | haeme-protein | 1 |
| 662 | histone-protein | 1 |
| 663 | chemical-protein | 4 |
| 664 | protein-protein | 179 |
| 665 | efficiency-property-pharmacology-target-protein | 1 |
| 666 | energy-by-protein | 1 |
| 667 | protein/protein | 5 |
| 668 | 14-3-3ζ-phosphoprotein | 1 |
| 669 | cell-apolipoprotein | 1 |
| 670 | protein–protein | 1 |
| 671 | initiator-origin | 1 |
| 672 | gene-b-vitamin | 1 |
| 673 | mdm2-nucleophosmin | 1 |
| 674 | estrogen-serotonin | 1 |
| 675 | intramyotubularin | 1 |
| 676 | kindlin-3-β2-integrin | 1 |
| 677 | inv-integrin | 1 |
| 678 | ap-3-clathrin | 2 |
| 679 | ibuprofen/aspirin | 1 |
| 680 | 14-3-3ζ-ezrin | 1 |
| 681 | actin-myosin | 11 |
| 682 | ay23-trypsin | 1 |
| 683 | er-striatin | 1 |
| 684 | erα/chromatin | 1 |
| 685 | drug-statin | 7 |
| 686 | aldolase-actin | 1 |
| 687 | carbohydrate-lectin | 1 |
| 688 | glycan-lectin | 1 |
| 689 | vwf-galectin | 1 |
| 690 | dronedarone-digoxin | 1 |
| 691 | integrin-toxin | 1 |
| 692 | antibody/toxin | 1 |
| 693 | fe-o-mn | 2 |
| 694 | mn-o-mn | 1 |
| 695 | au-mn | 1 |
| 696 | bbmn | 1 |
| 697 | water-hydrocarbon | 1 |
| 698 | group-region | 1 |
| 699 | treatment-by-region | 2 |
| 700 | anion-anion | 2 |
| 701 | protein-polyanion | 1 |
| 702 | copper-prion | 1 |
| 703 | caffeine-extraversion | 1 |
| 704 | group*session | 2 |
| 705 | modality-session | 1 |
| 706 | non-redundant-exclusion | 1 |
| 707 | pi-cation | 3 |
| 708 | cation-cation | 5 |
| 709 | π-cation | 5 |
| 710 | tds×medication | 1 |
| 711 | snp-education | 3 |
| 712 | condition-by-education | 1 |
| 713 | ethnicity-by-education | 1 |
| 714 | group×time×education | 1 |
| 715 | non-radiation | 3 |
| 716 | nonradiation | 4 |
| 717 | subject-by-formulation | 3 |
| 718 | electron-vibration | 2 |
| 719 | gene-concentration | 1 |
| 720 | stress-hemoconcentration | 2 |
| 721 | prerandomisation | 11 |
| 722 | end-orientation | 1 |
| 723 | trait×situation | 2 |
| 724 | expectations-realization | 1 |
| 725 | object-action | 1 |
| 726 | response-prediction | 1 |
| 727 | high-friction | 2 |
| 728 | preinstruction | 2 |
| 729 | time-by-condition | 4 |
| 730 | many-to-one-by-condition | 1 |
| 731 | gender×condition | 1 |
| 732 | reward-cognition | 1 |
| 733 | emotion-cognition | 2 |
| 734 | wm-attention | 1 |
| 735 | genotype-intervention | 1 |
| 736 | genotype-by-intervention | 2 |
| 737 | complexity-by-intervention | 1 |
| 738 | group-by-emotion | 2 |
| 739 | non-adsorption | 1 |
| 740 | lens-solution | 4 |
| 741 | human-raccoon | 1 |
| 742 | calcium-iron | 1 |
| 743 | core/electron-electron | 1 |
| 744 | nucleo-cytoskeleton | 1 |
| 745 | plasmon-exciton | 2 |
| 746 | cross-exon | 1 |
| 747 | animal-born | 1 |
| 748 | previously-unknown | 2 |
| 749 | crown-to-crown | 1 |
| 750 | phytate-zn | 1 |
| 751 | br⋯n | 1 |
| 752 | -ph···co | 1 |
| 753 | cc⋯ho | 1 |
| 754 | lumo-lumo | 1 |
| 755 | guanine-zno | 1 |
| 756 | br⋯onitro | 1 |
| 757 | /kaiso | 1 |
| 758 | plant-nto | 1 |
| 759 | te⋯o | 1 |
| 760 | carom-h⋯o | 1 |
| 761 | se···o | 1 |
| 762 | ch···o | 2 |
| 763 | nh···o | 4 |
| 764 | s···o | 2 |
| 765 | mg-p | 1 |
| 766 | yl.chn1p/ssa1p | 1 |
| 767 | sept-ap | 1 |
| 768 | mu-9-csap | 2 |
| 769 | ethnicity-by-ep | 1 |
| 770 | bjp-thp | 1 |
| 771 | gch1-chip | 1 |
| 772 | mor/morip | 1 |
| 773 | snp-snp | 2 |
| 774 | anti-tnp/tnp | 1 |
| 775 | kissing-loop | 4 |
| 776 | sp-a/crp | 2 |
| 777 | aea-hsp | 1 |
| 778 | time*group | 6 |
| 779 | treatment-by-age-group | 2 |
| 780 | time-group | 11 |
| 781 | time-by-group | 31 |
| 782 | between-ed-subgroup | 1 |
| 783 | treatment-subgroup | 10 |
| 784 | treatment-by-subgroup | 14 |
| 785 | reported.subgroup | 1 |
| 786 | time×group | 8 |
| 787 | predictor×group | 1 |
| 788 | pcsk9-ldl-r | 1 |
| 789 | ventricular-ventricular | 8 |
| 790 | tumor-vascular | 1 |
| 791 | antiperiplanar | 1 |
| 792 | pmhc-tcr | 1 |
| 793 | -ph···cr | 1 |
| 794 | hsp70-hla-dr | 1 |
| 795 | rubber-rubber | 1 |
| 796 | filler-rubber | 1 |
| 797 | intake-producer | 1 |
| 798 | researcher-provider | 1 |
| 799 | time-gender | 1 |
| 800 | digoxin-gender | 1 |
| 801 | treatment-gender | 2 |
| 802 | age-by-gender | 1 |
| 803 | gene-by-gender | 1 |
| 804 | treatment-by-gender | 4 |
| 805 | δglucose×gender | 1 |
| 806 | ram-by-extender | 1 |
| 807 | confounder | 96 |
| 808 | treatment-marker | 1 |
| 809 | treatment-biomarker | 5 |
| 810 | treatment-by-biomarker | 3 |
| 811 | pseudo-jahn-teller | 1 |
| 812 | rubber-filler | 1 |
| 813 | inter-trimer | 1 |
| 814 | staff-consumer | 1 |
| 815 | nanoparticle-polymer | 1 |
| 816 | api/polymer | 1 |
| 817 | th-partner | 1 |
| 818 | actor-partner | 5 |
| 819 | cross-partner | 3 |
| 820 | sex-partner | 1 |
| 821 | c60-water | 1 |
| 822 | fullerene-water | 1 |
| 823 | amine-water | 1 |
| 824 | light-water | 1 |
| 825 | treatment-by-center | 3 |
| 826 | regulator-promoter | 1 |
| 827 | roter | 13 |
| 828 | flavonoid-abc-transporter | 1 |
| 829 | metal-to-cluster | 1 |
| 830 | ion-matter | 1 |
| 831 | laser-matter | 1 |
| 832 | staff-caregiver | 3 |
| 833 | intra-layer | 1 |
| 834 | treatment-by-gfr | 2 |
| 835 | system-reservoir | 2 |
| 836 | pcsk9/ldlr | 1 |
| 837 | second-neighbor | 2 |
| 838 | non-nearest-neighbor | 1 |
| 839 | hormone-brain-behavior | 1 |
| 840 | environment-behavior | 1 |
| 841 | nanoparticle-tumor | 1 |
| 842 | a-minor | 1 |
| 843 | host-donor | 1 |
| 844 | trainee-supervisor | 1 |
| 845 | treatment-by-investigator | 1 |
| 846 | treatment-by-factor | 2 |
| 847 | parasite-vector | 1 |
| 848 | drug-by-predictor | 1 |
| 849 | gal-3-inhibitor | 2 |
| 850 | auditory-to-motor | 1 |
| 851 | tnf-alpha-tnf-receptor | 1 |
| 852 | drug-receptor | 5 |
| 853 | hn-receptor | 1 |
| 854 | hsp-receptor | 1 |
| 855 | inducer-receptor | 1 |
| 856 | coronavirus-receptor | 1 |
| 857 | apelin/receptor | 1 |
| 858 | cholinoreceptor | 1 |
| 859 | csa-β-adrenoceptor | 1 |
| 860 | protein-flavor | 1 |
| 861 | tslp-tslpr | 1 |
| 862 | meevd-tpr | 1 |
| 863 | v-rr | 2 |
| 864 | rbp4-ttr | 1 |
| 865 | 3'-bte-5'-utr | 1 |
| 866 | cl-s | 1 |
| 867 | s···n/s | 1 |
| 868 | kubas | 1 |
| 869 | chias | 4 |
| 870 | oestrogen-ras | 1 |
| 871 | no-ras | 1 |
| 872 | stas-stas | 1 |
| 873 | drug-herbs | 1 |
| 874 | treatment×cs | 1 |
| 875 | infusion-rates | 1 |
| 876 | sex-diabetes | 2 |
| 877 | herbs-drugs | 1 |
| 878 | feedback-this | 1 |
| 879 | genotype-by-diagnosis | 2 |
| 880 | gender-by-diagnosis | 1 |
| 881 | treatment-by-diagnosis | 1 |
| 882 | group*weeks | 1 |
| 883 | host-pathogens | 1 |
| 884 | pabp-ars | 1 |
| 885 | operators/analysers | 1 |
| 886 | severity-of-illness | 3 |
| 887 | estrogen-stress | 1 |
| 888 | n-ts | 1 |
| 889 | gender×mets | 1 |
| 890 | arms-by-visits | 1 |
| 891 | drug-excipients | 1 |
| 892 | sperm/mucus | 2 |
| 893 | host-fungus | 2 |
| 894 | interologous | 1 |
| 895 | non-dichotomous | 1 |
| 896 | host-virus | 4 |
| 897 | treatment-by-ed-status | 1 |
| 898 | ozone-heat | 2 |
| 899 | rwa-wheat | 1 |
| 900 | nicotine-paraquat | 1 |
| 901 | product-subject | 1 |
| 902 | therapist-subject | 1 |
| 903 | diphylla-insect | 1 |
| 904 | fungus-insect | 1 |
| 905 | mirna-target | 1 |
| 906 | ligand-target | 6 |
| 907 | disease-target | 1 |
| 908 | drug-target | 11 |
| 909 | tf's-target | 1 |
| 910 | database/target | 1 |
| 911 | gene*diet | 1 |
| 912 | bmi*diet | 1 |
| 913 | proteome-diet | 1 |
| 914 | gene-diet | 26 |
| 915 | gender-to-diet | 1 |
| 916 | snp-diet | 4 |
| 917 | strain×diet | 1 |
| 918 | treatment-by-subset | 2 |
| 919 | proline/g-quartet | 1 |
| 920 | treatment-by-weight | 1 |
| 921 | dye-light | 1 |
| 922 | spin–orbit | 1 |
| 923 | treatment-visit | 2 |
| 924 | group-by-visit | 1 |
| 925 | treatment-by-visit | 1 |
| 926 | post-assault | 2 |
| 927 | parent/infant | 2 |
| 928 | material-implant | 1 |
| 929 | nicotine-stimulant | 1 |
| 930 | dexamethasone/aprepitant | 1 |
| 931 | panic-relevant | 6 |
| 932 | staff-resident | 1 |
| 933 | ser19-phosphorylation-dependent | 1 |
| 934 | pharmacological-independent | 1 |
| 935 | translation-independent | 2 |
| 936 | iop-independent | 2 |
| 937 | physician-student | 1 |
| 938 | host-agent | 1 |
| 939 | peer-client | 2 |
| 940 | program-by-client | 2 |
| 941 | 14-3-3ζ-client | 1 |
| 942 | 14-3-3/client | 1 |
| 943 | caseworker-recipient | 1 |
| 944 | drug-excipient | 5 |
| 945 | gene-nutrient | 4 |
| 946 | exercise-nutrient | 1 |
| 947 | drug-nutrient | 4 |
| 948 | nutrient-nutrient | 3 |
| 949 | tfap2b-macronutrient | 1 |
| 950 | drug-micronutrient | 1 |
| 951 | coach-patient | 1 |
| 952 | pharmacotherapist-patient | 1 |
| 953 | clinician‒patient | 1 |
| 954 | post-cement | 1 |
| 955 | drug-supplement | 5 |
| 956 | supplement-supplement | 1 |
| 957 | sex-by-supplement | 1 |
| 958 | genetic-environment | 1 |
| 959 | genome-environment | 1 |
| 960 | gene-environment | 72 |
| 961 | gene-by-environment | 9 |
| 962 | genotype-by-environment | 1 |
| 963 | qtl-by-environment | 1 |
| 964 | genetic/environment | 1 |
| 965 | gene/environment | 4 |
| 966 | human/environment | 1 |
| 967 | fungal/crop/environment | 1 |
| 968 | genes/environment | 4 |
| 969 | gene×environment | 2 |
| 970 | race-treatment | 2 |
| 971 | compliance-treatment | 2 |
| 972 | aptitude-treatment | 5 |
| 973 | age-treatment | 2 |
| 974 | sex-age-treatment | 1 |
| 975 | time-treatment | 5 |
| 976 | gene-treatment | 6 |
| 977 | genotype-treatment | 4 |
| 978 | centre-treatment | 1 |
| 979 | covariate-treatment | 4 |
| 980 | attribute-treatment | 3 |
| 981 | subgroup-treatment | 1 |
| 982 | gender-treatment | 2 |
| 983 | marker-treatment | 1 |
| 984 | subject-treatment | 3 |
| 985 | unit-treatment | 4 |
| 986 | age-by-treatment | 5 |
| 987 | variable-by-treatment | 1 |
| 988 | time-by-treatment | 18 |
| 989 | gene-by-treatment | 3 |
| 990 | baseline-by-treatment | 6 |
| 991 | stent-type-by-treatment | 1 |
| 992 | genotype-by-treatment | 4 |
| 993 | covariate-by-treatment | 1 |
| 994 | lvef-by-treatment | 1 |
| 995 | person-by-treatment | 1 |
| 996 | subgroup-by-treatment | 3 |
| 997 | age-by-gender-by-treatment | 1 |
| 998 | moderator-by-treatment | 1 |
| 999 | visit-by-treatment | 1 |
| 1000 | sex-by-treatment | 4 |
| 1001 | study-by-treatment | 3 |
| 1002 | histology-by-treatment | 2 |
| 1003 | surgery-by-treatment | 1 |
| 1004 | activity-treatment | 1 |
| 1005 | genotype/treatment | 1 |
| 1006 | bullxtreatment | 1 |
| 1007 | osa×treatment | 1 |
| 1008 | time×treatment | 9 |
| 1009 | sex×treatment | 1 |
| 1010 | doctor-parent | 1 |
| 1011 | infant/parent | 1 |
| 1012 | empathy×content | 1 |
| 1013 | intra-solvent | 1 |
| 1014 | protein-solvent | 2 |
| 1015 | plant-symbiont | 1 |
| 1016 | child-robot | 1 |
| 1017 | human-robot | 6 |
| 1018 | shoot-root | 1 |
| 1019 | pioglitazone-by-rt | 1 |
| 1020 | lung-heart | 3 |
| 1021 | arterial-heart | 1 |
| 1022 | human-forest | 1 |
| 1023 | society-forest | 1 |
| 1024 | host/guest | 1 |
| 1025 | bacteria-host | 2 |
| 1026 | phytoplasma-host | 1 |
| 1027 | microbe-host | 3 |
| 1028 | cyanophage-host | 1 |
| 1029 | microbial-host | 1 |
| 1030 | virus-bacterial-host | 1 |
| 1031 | viral-host | 1 |
| 1032 | pathogen-host | 2 |
| 1033 | fungus-host | 1 |
| 1034 | virus-host | 17 |
| 1035 | host-host | 1 |
| 1036 | hcv-host | 2 |
| 1037 | virus/host | 2 |
| 1038 | g×t | 2 |
| 1039 | au-au | 2 |
| 1040 | amyloid-tau | 2 |
| 1041 | tau-tau | 2 |
| 1042 | au···au | 1 |
| 1043 | nfs1-isu | 1 |
| 1044 | n-v | 1 |
| 1045 | std-hiv | 1 |
| 1046 | sex-by-tstv | 1 |
| 1047 | gal-3/bax | 1 |
| 1048 | prosody-syntax | 1 |
| 1049 | rs738409-sex | 2 |
| 1050 | age-by-sex | 2 |
| 1051 | gene-by-sex | 1 |
| 1052 | genotype-by-sex | 1 |
| 1053 | snp-by-sex | 1 |
| 1054 | group-by-sex | 1 |
| 1055 | treatment-by-sex | 3 |
| 1056 | group×time×sex | 3 |
| 1057 | case-mix | 56 |
| 1058 | cell–matrix | 1 |
| 1059 | 14-3-3/cby | 2 |
| 1060 | -lacy | 1 |
| 1061 | pt/vacancy | 1 |
| 1062 | drug-pregnancy | 1 |
| 1063 | mind-brain-body | 1 |
| 1064 | higher-body | 1 |
| 1065 | four-body | 1 |
| 1066 | syntax-prosody | 1 |
| 1067 | treatment-by-study | 2 |
| 1068 | lung-kidney | 2 |
| 1069 | treatment-by-histology | 4 |
| 1070 | day*energy | 1 |
| 1071 | child-family | 1 |
| 1072 | subgroup-by-therapy | 1 |
| 1073 | flory | 1 |
| 1074 | intra-sensory | 2 |
| 1075 | explanatory | 618 |
| 1076 | gastrointestinal-respiratory | 1 |
| 1077 | drug-laboratory | 3 |
| 1078 | growth/inhibitory | 1 |
| 1079 | contributory | 149 |
| 1080 | drug-cranberry | 1 |
| 1081 | time-of-entry | 1 |
| 1082 | treatment-by-country | 2 |
| 1083 | inter-moiety | 1 |
| 1084 | treatment-by-anxiety | 1 |
| 1085 | hba1c/ethnicity | 1 |
| 1086 | drug-personality | 1 |
| 1087 | rtms-laterality | 1 |
| 1088 | mode×intensity | 1 |
| 1089 | br⋯ometh-oxy | 1 |
| 1090 | solvent-1,2,3-trz | 1 |
| 1091 | ammonium-quartz | 1 |
| 1092 | anion-π | 6 |
| 1093 | cation-π | 5 |
| 1094 | π-π | 268 |
| 1095 | π–π | 5 |
| 1096 | c-h⋯π | 93 |
| 1097 | ch⋯π | 1 |
| 1098 | c=o⋯π | 1 |
| 1099 | s-h·π | 1 |
| 1100 | c-h···π | 16 |
| 1101 | metal···π | 1 |
| 1102 | π···π | 13 |
| 1103 | p53/14-3-3σ | 1 |
| 1104 | nf→σ | 1 |
| 1105 | synaptopodin/14-3-3β | 1 |
| 1106 | catalase-aβ | 1 |
| 1107 | irf3/ikkβ | 1 |
| 1108 | β2/14-3-3-ζ | 1 |
| 1109 | as/14-3-3η | 2 |